Interaction of Cannabis Use and Aging: From Molecule to Mind

References

• Abuhasira, R., Schleider, L. B., Mechoulam, R., & Novack, V. (2018). Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly. European Journal of Internal Medicine, 49, 44–50. doi:10.1016/j.ejim.2018.01.019
   PubMed Web of Science ®Google Scholar
• Acquas, E., Pisanu, A., Marrocu, P., & Di Chiara, G. (2000). Cannabinoid CB1 receptor agonists increase rat cortical and hippocampal acetylcholine release in vivo. European Journal of Pharmacology, 401(2), 179–185. doi:10.1016/S0014-2999(00)00403-9
   PubMed Web of Science ®Google Scholar
• Agnati, L. F., Fuxe, K., Zoli, M., Ozini, I., Toffano, G., & Ferraguti, F. (1986). A correlation analysis of the regional distribution of central enkephalin and beta-endorphin immunoreactive terminals and of opiate receptors in adult and old male rats. Evidence for the existence of two main types of communication in the central nervous system: The volume transmission and the wiring transmission. Acta Physiologica Scandinavica, 128(2), 201–207. doi:10.1111/j.1748-1716.1986.tb07967.x
   PubMedGoogle Scholar
• Aguado, T., Monory, K., Palazuelos, J., Stella, N., Cravatt, B., Lutz, B., … Galve-Roperh, I. (2005). The endocannabinoid system drives neural progenitor proliferation. The FASEB Journal, 19(12), 1704–1706. doi:10.1096/fj.05-3995fje
   PubMedGoogle Scholar
• Ahmad, T., Lauzon, N. M., de Jaeger, X., & Laviolette, S. R. (2013). Cannabinoid transmission in the prelimbic cortex bidirectionally controls opiate reward and aversion signaling through dissociable kappa versus μ-opiate receptor dependent mechanisms. The Journal of Neuroscience, 33(39), 15642–15651. doi:10.1523/JNEUROSCI.1686-13.2013
   PubMed Web of Science ®Google Scholar
• Akers, K. G., Martinez-Canabal, A., Restivo, L., Yiu, A. P., De Cristofaro, A., Hsiang, H.-L., … Frankland, P. W. (2014). Hippocampal neurogenesis regulates forgetting during adulthood and infancy. Science, 344(6184), 598–602. doi:10.1126/science.1248903
   PubMed Web of Science ®Google Scholar
• Akiyama, H., Barger, S., Barnum, S., Bradt, B., Bauer, J., Cole, G. M., … Wyss-Coray, T. (2000). Inflammation and Alzheimer's disease. Neurobiology of Aging, 21(3), 383–421.
   PubMed Web of Science ®Google Scholar
• Albayram, O., Alferink, J., Pitsch, J., Piyanova, A., Neitzert, K., Poppensieker, K., … Bilkei-Gorzo, A. (2011). Role of CB1 cannabinoid receptors on gabaergic neurons in brain aging. Proceedings of the National Academy of Sciences of Sciences, 108(27), 11256–11261. doi:10.1073/pnas.1016442108
   PubMed Web of Science ®Google Scholar
• Albayram, O., Bilkei-Gorzo, A., & Zimmer, A. (2012). Loss of CB1 receptors leads to differential age-related changes in reward-driven learning and memory. Frontiers in Aging Neuroscience, 4, 34. doi:10.3389/fnagi.2012.00034
   PubMed Web of Science ®Google Scholar
• Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986). Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annual Review of Neuroscience, 9(1), 357–381. doi:10.1146/annurev.ne.09.030186.002041
   PubMed Web of Science ®Google Scholar
• Alger, B. E. (2002). Retrograde signaling in the regulation of synaptic transmission: Focus on endocannabinoids. Progress in Neurobiology, 68(4), 247–286.
   PubMed Web of Science ®Google Scholar
• Al-Hasani, R., & Bruchas, M. R. (2011). Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology, 115(6), 1363–1381. doi:10.1097/ALN.0b013e318238bba6
   PubMed Web of Science ®Google Scholar
• Allen, J. S., Bruss, J., Brown, C. K., & Damasio, H. (2005). Normal neuroanatomical variation due to age: The major lobes and a parcellation of the temporal region. Neurobiology of Aging, 26(9), 1245–1260. doi:10.1016/j.neurobiolaging.2005.05.023
   PubMed Web of Science ®Google Scholar
• Alzheimer, A. (1911). Þber eigenartige krankheitsfälle des späteren alters. Zeitschrift Für Die Gesamte Neurologie Und Psychiatrie, 4(1), 356–385. doi:10.1007/BF02866241
   Google Scholar
• Amenta, F., Zaccheo, D., & Collier, W. L. (1991). Neurotransmitters, neuroreceptors and aging. Mechanisms of Ageing and Development, 61(3), 249–273. doi:10.1016/0047-6374(91)90059-9
   PubMed Web of Science ®Google Scholar
• Amieva, H., Le Goff, M., Millet, X., Orgogozo, J. M., Pérès, K., Barberger-Gateau, P., … Dartigues, J. F. (2008). Prodromal Alzheimer's Disease: Successive emergence of the clinical symptoms. Annals of Neurology, 64(5), 492–498. doi:10.1002/ana.21509
   PubMed Web of Science ®Google Scholar
• Angelucci, F., Ricci, V., Spalletta, G., Pomponi, M., Tonioni, F., Caltagirone, C., & Bria, P. (2008). Reduced serum concentrations of nerve growth factor, but not brain-derived neurotrophic factor, in chronic cannabis abusers. European Neuropsychopharmacology, 18(12), 882–887. doi:10.1016/j.euroneuro.2008.07.008
   PubMed Web of Science ®Google Scholar
• Apostolova, L. G., Dutton, R. A., Dinov, I. D., Hayashi, K. M., Toga, A. W., Cummings, J. L., & Thompson, P. M. (2006). Conversion of mild cognitive impairment to Alzheimer Disease predicted by hippocampal atrophy maps. Archives of Neurology, 63(5), 693–699. doi:10.1001/archneur.63.5.693
   PubMedGoogle Scholar
• Arévalo‐Martín, A., García‐Ovejero, D., Gomez, O., Rubio‐Araiz, A., Navarro‐Galve, B., Guaza, C., … Molina‐Holgado, F. (2008). CB2 cannabinoid receptors as an emerging target for demyelinating diseases: From neuroimmune interactions to cell replacement strategies. British Journal of Pharmacology, 153(2), 216–225. doi:10.1038/sj.bjp.0707466
   PubMed Web of Science ®Google Scholar
• Arnone, D., Barrick, T. R., Chengappa, S., Mackay, C., Clark, C. A., & Abou-Saleh, M. (2008). Corpus callosum damage in heavy marijuana use: Preliminary evidence from diffusion tensor tractography and tract-based spatial statistics. NeuroImage, 41(3), 1067–1074. doi:10.1016/j.neuroimage.2008.02.064
   PubMed Web of Science ®Google Scholar
• Arora, K., Qualls, S. H., Bobitt, J., Lum, H. D., Milavetz, G., Croker, J., & Kaskie, B. (2019). Measuring attitudes toward medical and recreational cannabis among older adults in Colorado. The Gerontologist, 1–10. doi:10.1093/geront/gnz054
   PubMedGoogle Scholar
• Ashton, J. C., & Glass, M. (2007). The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration. Current Neuropharmacology, 5(2), 73–80. doi:10.2174/157015907780866884
   PubMed Web of Science ®Google Scholar
• Aso, E., Sanchez-Pla, A., Vegas-Lozano, E., Maldonado, R., & Ferrer, I. (2014). Cannabis-Based medicine reduces multiple pathological processes in Abetapp/PS1 mice. Journal of Alzheimer's Disease, 43(3), 977–991. doi:10.3233/JAD-141014
   Web of Science ®Google Scholar
• Auer, R., Vittinghoff, E., Yaffe, K., Künzi, A., Kertesz, S. G., Levine, D. A., … Pletcher, M. J. (2016). Association between lifetime marijuana use and cognitive function in middle age: The coronary artery risk development in young adults (CARDIA) study. JAMA Internal Medicine, 176(3), 352–361. doi:10.1001/jamainternmed.2015.7841
   PubMed Web of Science ®Google Scholar
• Azaryan, A. V., Clock, B. J., & Cox, B. M. (1996). Mu opioid receptor mRNA in nucleus accumbens is elevated following dopamine receptor activation. Neurochemical Research, 21(11), 1411–1415. doi:10.1007/BF02532382
   PubMed Web of Science ®Google Scholar
• Backman, L., Ginovart, N., Dixon, R. A., Wahlin, T. B., Wahlin, A., Halldin, C., & Farde, L. (2000). Age-Related cognitive deficits mediated by changes in the striatal dopamine system. American Journal of Psychiatry, 157(4), 635–637. doi:10.1176/ajp.157.4.635
   PubMed Web of Science ®Google Scholar
• Bäckman, L., Karlsson, S., Fischer, H., Karlsson, P., Brehmer, Y., Rieckmann, A., … Nyberg, L. (2011). Dopamine D1 receptors and age differences in brain activation during working memory. Neurobiology of Aging, 32(10), 1849–1856. doi:10.1016/j.neurobiolaging.2009.10.018
   PubMed Web of Science ®Google Scholar
• Baker, D. J., & Petersen, R. C. (2018). Cellular senescence in brain aging and neurodegenerative diseases: Evidence and perspectives. Journal of Clinical Investigation, 128(4), 1208–1216. doi:10.1172/JCI95145
   PubMed Web of Science ®Google Scholar
• Bambico, F. R., Katz, N., Debonnel, G., & Gobbi, G. (2007). Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex. Journal of Neuroscience, 27(43), 11700–11711. doi:10.1523/JNEUROSCI.1636-07.2007
   PubMed Web of Science ®Google Scholar
• Barnes, C. A., & McNaughton, B. L. (1980). Physiological compensation for loss of afferent synapses in rat hippocampal granule cells during senescence. The Journal of Physiology, 309(1), 473–485. doi:10.1113/jphysiol.1980.sp013521
   PubMedGoogle Scholar
• Barnes, C., Rao, G., & Houston, F. (2000). LTP induction threshold change in old rats at the perforant path–granule cell synapse. Neurobiology of Aging, 21(5), 613–620. doi:10.1016/S0197-4580(00)00163-9
   PubMed Web of Science ®Google Scholar
• Bartsch, T., & Wulff, P. (2015). The hippocampus in aging and disease: From plasticity to vulnerability. Neuroscience, 309, 1–16. doi:10.1016/j.neuroscience.2015.07.084
   Google Scholar
• Basbaum, A. I., & Fields, H. L. (1984). Endogenous pain control systems: Brainstem spinal pathways and endorphin circuitry. Annual Review of Neuroscience, 7(1), 309–338. doi:10.1146/annurev.ne.07.030184.001521
   PubMedGoogle Scholar
• Beale, C., Broyd, S. J., Chye, Y., Suo, C., Schira, M., Galettis, P., … Solowij, N. (2018). Prolonged cannabidiol treatment effects on hippocampal subfield volumes in current cannabis users. Cannabis and Cannabinoid Research, 3(1), 94–107. doi:10.1089/can.2017.0047
   PubMedGoogle Scholar
• Becker, B., Wagner, D., Gouzoulis-Mayfrank, E., Spuentrup, E., & Daumann, J. (2010). Altered parahippocampal functioning in cannabis users is related to the frequency of use. Psychopharmacology, 209(4), 361–374. doi:10.1007/s00213-010-1805-z
   PubMed Web of Science ®Google Scholar
• Berghuis, P., Dobszay, M. B., Wang, X., Spano, S., Ledda, F., Sousa, K. M., … Harkany, T. (2005). Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor. Proceedings of the National Academy of Sciences of Sciences, 102(52), 19115–19120. doi:10.1073/pnas.0509494102
   PubMed Web of Science ®Google Scholar
• Berghuis, P., Rajnicek, A. M., Morozov, Y. M., Ross, R. A., Mulder, J., Urban, G. M., … Harkany, T. (2007). Hardwiring the brain: Endocannabinoids shape neuronal connectivity. Science, 316(5828), 1212–1216. doi:10.1126/science.1137406
   PubMed Web of Science ®Google Scholar
• Berke, J. D., & Hyman, S. E. (2000). Addiction, dopamine, and the molecular mechanisms of memory. Neuron, 25(3), 515–532. doi:10.1016/S0896-6273(00)81056-9
   PubMed Web of Science ®Google Scholar
• Berrendero, F., Romero, J., Garcı́a-Gil, L., Suarez, I., De la Cruz, P., Ramos, J. A., & Fernández-Ruiz, J. J. (1998). Changes in cannabinoid receptor binding and mRNA levels in several brain regions of aged rats. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1407(3), 205–214. doi:10.1016/S0925-4439(98)00042-8
   PubMed Web of Science ®Google Scholar
• Berridge, C. W., & Waterhouse, B. D. (2003). The locus coeruleus-noradrenergic system: Modulation of behavioral state and state-dependent cognitive processes. Brain Research Reviews, 42(1), 33–84. doi:10.1016/S0165-0173(03)00143-7
   PubMedGoogle Scholar
• Berridge, K. C., & Robinson, T. E. (1998). What is the role of dopamine in reward: Hedonic impact, reward learning, or incentive salience? Brain Research Reviews, 28(3), 309–369. doi:10.1016/S0165-0173(98)00019-8
   PubMed Web of Science ®Google Scholar
• Berry, A. S., Shah, V. D., Baker, S. L., Vogel, J. W., O'Neil, J. P., Janabi, M., … Jagust, W. J. (2016). Aging affects dopaminergic neural mechanisms of cognitive flexibility. The Journal of Neuroscience, 36(50), 12559–12569. doi:10.1523/JNEUROSCI.0626-16.2016
   PubMed Web of Science ®Google Scholar
• Bhattacharyya, S., Morrison, P. D., Fusar-Poli, P., Martin-Santos, R., Borgwardt, S., Winton-Brown, T., … McGuire, P. K. (2010). Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology, 35(3), 764–774. doi:10.1038/npp.2009.184
   PubMed Web of Science ®Google Scholar
• Bilkei-Gorzo, A. (2012). The endocannabinoid system in normal and pathological brain ageing. Philosophical Transactions of the Royal Society B: Biological Sciences, 367(1607), 3326–3341. doi:10.1098/rstb.2011.0388
   PubMed Web of Science ®Google Scholar
• Bilkei-Gorzo, A., Albayram, O., Draffehn, A., Michel, K., Piyanova, A., Oppenheimer, H., … Zimmer, A. (2017). A chronic low dose of Δ9-tetrahydrocannabinol (THC) restores cognitive function in old mice. Nature Medicine, 23(6), 782–787. doi:10.1038/nm.4311
   PubMed Web of Science ®Google Scholar
• Bilkei-Gorzo, A., Drews, E., Albayram, Ö., Piyanova, A., Gaffal, E., Tueting, T., … Zimmer, A. (2012). Early onset of aging-like changes is restricted to cognitive abilities and skin structure in cnr1−/− mice. Neurobiology of Aging, 33(1), 200.e11–22. doi:10.1016/j.neurobiolaging.2010.07.009
   Web of Science ®Google Scholar
• Black, P., & Joseph, L. J. (2014). Still dazed and confused: Midlife marijuana use by the Baby Boom Generation. Deviant Behavior, 35(10), 822–841. doi:10.1080/01639625.2014.889994
   Web of Science ®Google Scholar
• Blier, P., & de Montigny, C. (1999). Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders. Neuropsychopharmacology, 21(2), 91S–98S. doi:10.1016/S0893-133X(99)00036-6
   PubMed Web of Science ®Google Scholar
• Bloomfield, M. A., Ashok, A. H., Volkow, N. D., & Howes, O. D. (2016). The effects of Δ 9-tetrahydrocannabinol on the dopamine system. Nature, 539(7629), 369–377. doi:10.1038/nature20153
   PubMed Web of Science ®Google Scholar
• Bloomfield, M. A., Morgan, C. J., Kapur, S., Curran, H. V., & Howes, O. D. (2014). The link between dopamine function and apathy in cannabis users: An [18 F]-DOPA PET imaging study. Psychopharmacology, 231(11), 2251–2259. doi:10.1007/s00213-014-3523-4
   PubMed Web of Science ®Google Scholar
• Bohme, G., Laville, M., Ledent, C., Parmentier, M., & Imperato, A. (1999). Enhanced long-term potentiation in mice lacking cannabinoid CB1 receptors. Neuroscience, 95(1), 5–7. doi:10.1016/S0306-4522(99)00483-2
   Web of Science ®Google Scholar
• Boileau, I., Mansouri, E., Williams, B., Le Foll, B., Rusjan, P., Mizrahi, R., … Tong, J. (2016). Fatty acid amide hydrolase binding in brain of cannabis users: Imaging with the novel radiotracer [11C]CURB. Biological Psychiatry, 80(9), 691–701. doi:10.1016/j.biopsych.2016.04.012
   PubMed Web of Science ®Google Scholar
• Bolla, K. I., Brown, K., Eldreth, D., Tate, K., & Cadet, J. (2002). Dose-related neurocognitive effects of marijuana use. Neurology, 59(9), 1337–1343. doi:10.1212/01.wnl.0000031422.66442.49
   PubMed Web of Science ®Google Scholar
• Bonnet, A. E., & Marchalant, Y. (2015). Potential therapeutical contributions of the endocannabinoid system towards aging and Alzheimer's disease. Aging and Disease, 6(5), 400–405. doi:10.14336/AD.2015.0617
   PubMed Web of Science ®Google Scholar
• Bossong, M. G., van Berckel, B. N., Boellaard, R., Zuurman, L., Schuit, R. C., Windhorst, A. D., … Kahn, R. S. (2009). Δ9-Tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology, 34(3), 759–766. doi:10.1038/npp.2008.138
   PubMed Web of Science ®Google Scholar
• Braun, U., Schäfer, A., Walter, H., Erk, S., Romanczuk-Seiferth, N., Haddad, L., … Bassett, D. S. (2015). Dynamic reconfiguration of frontal brain networks during executive cognition in humans. Proceedings of the National Academy of Sciences, 112(37), 11678–11683. doi:10.1073/pnas.1422487112
   PubMed Web of Science ®Google Scholar
• Brewer, J. A., & Potenza, M. N. (2008). The neurobiology and genetics of impulse control disorders: Relationships to drug addictions. Biochemical Pharmacology, 75(1), 63–75. doi:10.1016/j.bcp.2007.06.043
   PubMed Web of Science ®Google Scholar
• Broyd, S. J., van Hell, H. H., Beale, C., Yucel, M., & Solowij, N. (2016). Acute and chronic effects of cannabinoids on human cognition-a systematic review. Biological Psychiatry, 79(7), 557–567. doi:10.1016/j.biopsych.2015.12.002
   PubMed Web of Science ®Google Scholar
• Brumback, T., Castro, N., Jacobus, J., & Tapert, S. (2016). Effects of marijuana use on brain structure and function: Neuroimaging findings from a neurodevelopmental perspective. International Review of Neurobiology, 129, 33–65. doi:10.1016/bs.irn.2016.06.004
   PubMed Web of Science ®Google Scholar
• Buckner, R. L. (2004). Memory and executive function in aging and AD: Multiple factors that cause decline and reserve factors that compensate. Neuron, 44(1), 195–208. doi:10.1016/j.neuron.2004.09.006
   PubMed Web of Science ®Google Scholar
• Burggren, A. C., Siddarth, P., Mahmood, Z., London, E. D., Harrison, T. M., Merrill, D. A., … Bookheimer, S. Y. (2018). Subregional hippocampal thickness abnormalities in older adults with a history of heavy cannabis use. Cannabis and Cannabinoid Research, 3(1), 242–251. doi:10.1089/can.2018.0035
   PubMedGoogle Scholar
• Burke, S. N., & Barnes, C. A. (2006). Neural plasticity in the ageing brain. Nature Reviews Neuroscience, 7(1), 30–40. doi:10.1038/nrn1809
   PubMed Web of Science ®Google Scholar
• Bushlin, I., Rozenfeld, R., & Devi, L. A. (2010). Cannabinoid-opioid interactions during neuropathic pain and analgesia. Current Opinion in Pharmacology, 10(1), 80–86. doi:10.1016/j.coph.2009.09.009
   PubMed Web of Science ®Google Scholar
• Butovsky, E., Juknat, A., Goncharov, I., Elbaz, J., Eilam, R., Zangen, A., & Vogel, Z. (2005). In vivo up‐regulation of brain‐derived neurotrophic factor in specific brain areas by chronic exposure to Δ9‐tetrahydrocannabinol. Journal of Neurochemistry, 93(4), 802–811. doi:10.1111/j.1471-4159.2005.03074.x
   PubMedGoogle Scholar
• Buxbaum, D. (1972). Analgesic activity of 9-tetrahydrocannabinol in the rat and mouse. Psychopharmacologia, 25(3), 275–280.
   PubMedGoogle Scholar
• Calabrese, E. J., & Rubio-Casillas, A. (2018). Biphasic effects of THC in memory and cognition. European Journal of Clinical Investigation, 48(5), e12920. doi:10.1111/eci.12920
   PubMed Web of Science ®Google Scholar
• Camandola, S., & Mattson, M. P. (2017). Brain metabolism in health, aging, and neurodegeneration. The Embo Journal, 36(11), 1474–1492. doi:10.15252/embj.201695810
   PubMed Web of Science ®Google Scholar
• Cao, C., Li, Y., Liu, H., Bai, G., Mayl, J., Lin, X., … Cai, J. (2014). The potential therapeutic effects of THC on Alzheimer's Disease. Journal of Alzheimer's Disease, 42(3), 973–984. doi:10.3233/JAD-140093
   PubMed Web of Science ®Google Scholar
• Carliner, H., Brown, Q. L., Sarvet, A. L., & Hasin, D. S. (2017). Cannabis use, attitudes, and legal status in the US: A review. Preventive Medicine, 104, 13–23. doi:10.1016/j.ypmed.2017.07.008
   PubMed Web of Science ®Google Scholar
• Carracedo, A., Geelen, M. J., Diez, M., Hanada, K., Guzman, M., & Velasco, G. (2004). Ceramide sensitizes astrocytes to oxidative stress: Protective role of cannabinoids. Biochemical Journal, 380(2), 435–440. doi:10.1042/bj20031714
   PubMedGoogle Scholar
• Carroll, C., Zeissler, M. L., Hanemann, C., & Zajicek, J. (2012). Δ9‐tetrahydrocannabinol (Δ9‐THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's Disease. Neuropathology and Applied Neurobiology, 38(6), 535–547. doi:10.1111/j.1365-2990.2011.01248.x
   PubMed Web of Science ®Google Scholar
• Carta, G., Nava, F., & Gessa, G. L. (1998). Inhibition of hippocampal acetylcholine release after acute and repeated delta9-tetrahydrocannabinol in rats. Brain Research, 809(1), 1–4. doi:10.1016/S0006-8993(98)00738-0
   PubMed Web of Science ®Google Scholar
• Carvalho, A. F., Mackie, K., & Van Bockstaele, E. J. (2010). Cannabinoid modulation of limbic forebrain noradrenergic circuitry. European Journal of Neuroscience, 31(2), 286–301. doi:10.1111/j.1460-9568.2009.07054.x
   PubMed Web of Science ®Google Scholar
• Cascini, F., Aiello, C., & Di Tanna, G. (2012). Increasing delta-9-tetrahydrocannabinol (Delta-9-THC) content in herbal cannabis over time: Systematic review and meta-analysis. Current Drug Abuse Reviews, 5(1), 32–40. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/22150622.
   PubMedGoogle Scholar
• Castillo, A., Tolón, M., Fernández-Ruiz, J., Romero, J., & Martinez-Orgado, J. (2010). The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic–ischemic brain damage in mice is mediated by CB2 and adenosine receptors. Neurobiology of Disease, 37(2), 434–440. doi:10.1016/j.nbd.2009.10.023
   PubMed Web of Science ®Google Scholar
• Castillo, P. E., Younts, T. J., Chavez, A. E., & Hashimotodani, Y. (2012). Endocannabinoid signaling and synaptic function. Neuron, 76(1), 70–81. doi:10.1016/j.neuron.2012.09.020
   PubMed Web of Science ®Google Scholar
• Casu, M. A., Pisu, C., Sanna, A., Tambaro, S., Spada, G. P., Mongeau, R., & Pani, L. (2005). Effect of delta9-tetrahydrocannabinol on phosphorylated creb in rat cerebellum: An immunohistochemical study. Brain Research, 1048(1-2), 41–47. doi:10.1016/j.brainres.2005.04.053
   PubMed Web of Science ®Google Scholar
• Ceccarini, J., Kuepper, R., Kemels, D., van Os, J., Henquet, C., & Van Laere, K. (2015). [18F] MK‐9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users. Addiction Biology, 20(2), 357–367. doi:10.1111/adb.12116
   PubMed Web of Science ®Google Scholar
• Cha, Y. M., Jones, K. H., Kuhn, C. M., Wilson, W. A., & Swartzwelder, H. S. (2007). Sex differences in the effects of delta9-tetrahydrocannabinol on spatial learning in adolescent and adult rats. Behavioural Pharmacology, 18(5-6), 563–569. doi:10.1097/FBP.0b013e3282ee7b7e
   PubMed Web of Science ®Google Scholar
• Chamberlain, S. R., Muller, U., Blackwell, A. D., Robbins, T. W., & Sahakian, B. J. (2006). Noradrenergic modulation of working memory and emotional memory in humans. Psychopharmacology, 188(4), 397–407. doi:10.1007/s00213-006-0391-6
   PubMed Web of Science ®Google Scholar
• Chang, L., Yakupov, R., Cloak, C., & Ernst, T. (2006). Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation. Brain, 129(5), 1096–1112. doi:10.1093/brain/awl064
   PubMed Web of Science ®Google Scholar
• Chau, D. L., Walker, V., Pai, L., & Cho, L. M. (2008). Opiates and elderly: Use and side effects. Clinical Interventions in Aging, 3(2), 273–278.
   PubMed Web of Science ®Google Scholar
• Chen, J., Paredes, W., Li, J., Smith, D., Lowinson, J., & Gardner, E. L. (1990). Δ9-Tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology, 102(2), 156–162. doi:10.1007/BF02245916
   PubMed Web of Science ®Google Scholar
• Chevaleyre, V., Takahashi, K. A., & Castillo, P. E. (2006). Endocannabinoid-Mediated synaptic plasticity in the CNS. Annual Review of Neuroscience, 29(1), 37–76. doi:10.1146/annurev.neuro.29.051605.112834
   PubMedGoogle Scholar
• Childs, E., Lutz, J. A., & de Wit, H. (2017). Dose-Related effects of delta-9-THC on emotional responses to acute psychosocial stress. Drug and Alcohol Dependence, 177, 136–144. doi:10.1016/j.drugalcdep.2017.03.030
   PubMed Web of Science ®Google Scholar
• Choi, I. Y., Ju, C., Anthony Jalin, A. M., Lee, D. I., Prather, P. L., & Kim, W. K. (2013). Activation of cannabinoid CB2 Receptor-Mediated AMPK/CREB pathway reduces cerebral ischemic injury. The American Journal of Pathology, 182(3), 928–939. doi:10.1016/j.ajpath.2012.11.024
   PubMed Web of Science ®Google Scholar
• Choi, N. G., DiNitto, D. M., & Marti, C. N. (2016). Older-Adult marijuana users and ex-users: Comparisons of sociodemographic characteristics and mental and substance use disorders. Drug and Alcohol Dependence, 165, 94–102. doi:10.1016/j.drugalcdep.2016.05.023
   PubMed Web of Science ®Google Scholar
• Choi, N. G., DiNitto, D. M., Marti, C. N., & Choi, B. Y. (2016). Relationship between marijuana and other illicit drug use and depression/suicidal thoughts among late middle-aged and older adults. International Psychogeriatrics, 28(4), 577–589. doi:10.1017/S1041610215001738
   PubMed Web of Science ®Google Scholar
• Chung, Y. C., Shin, W.-H., Baek, J. Y., Cho, E. J., Baik, H. H., Kim, S. R., … Jin, B. K. (2016). CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson's disease. Experimental & Molecular Medicine, 48(1), e205. doi:10.1038/emm.2015.100
   PubMedGoogle Scholar
• Chye, Y., Christensen, E., Solowij, N., & Yücel, M. (2019). The endocannabinoid system and cannabidiol’s promise for the treatment of substance use disorder. Frontiers in Psychiatry, 10, 63. doi:10.3389/fpsyt.2019.00063
   PubMed Web of Science ®Google Scholar
• Chye, Y., Suo, C., Yucel, M., den Ouden, L., Solowij, N., & Lorenzetti, V. (2017). Cannabis-Related hippocampal volumetric abnormalities specific to subregions in dependent users. Psychopharmacology, 234(14), 2149–2157. doi:10.1007/s00213-017-4620-y
   PubMed Web of Science ®Google Scholar
• Cichewicz, D. L., & McCarthy, E. A. (2003). Antinociceptive synergy between δ9-tetrahydrocannabinol and opioids after oral administration. Journal of Pharmacology and Experimental Therapeutics, 304(3), 1010–1015. doi:10.1124/jpet.102.045575
   PubMed Web of Science ®Google Scholar
• Cichewicz, D. L., Martin, Z. L., Smith, F. L., & Welch, S. P. (1999). Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: Dose-response analysis and receptor identification. Journal of Pharmacology and Experimental Therapeutics, 289(2), 859–867. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/10215664
   PubMed Web of Science ®Google Scholar
• Colasanti, A., Rabiner, E. A., Lingford-Hughes, A., & Nutt, D. J. (2011). Opioids and anxiety. Journal of Psychopharmacology, 25(11), 1415–1433. doi:10.1177/0269881110367726
   PubMed Web of Science ®Google Scholar
• Compton, W. M., Han, B., Jones, C. M., Blanco, C., & Hughes, A. (2016). Marijuana use and use disorders in adults in the USA, 2002–14: Analysis of annual cross-sectional surveys. The Lancet Psychiatry, 3(10), 954–964. doi:10.1016/S2215-0366(16)30208-5
   PubMed Web of Science ®Google Scholar
• Conner, J. M., Franks, K. M., Titterness, A. K., Russell, K., Merrill, D. A., Christie, B. R., … Tuszynski, M. H. (2009). NGF is essential for hippocampal plasticity and learning. Journal of Neuroscience, 29(35), 10883–10889. doi:10.1523/JNEUROSCI.2594-09.2009
   PubMed Web of Science ®Google Scholar
• Cools, R. (2006). Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease. Neuroscience & Biobehavioral Reviews, 30(1), 1–23. doi:10.1016/j.neubiorev.2005.03.024
   PubMed Web of Science ®Google Scholar
• Cooper, Z. D., & Haney, M. (2009). Actions of delta-9-tetrahydrocannabinol in cannabis: Relation to use, abuse, dependence. International Review of Psychiatry, 21(2), 104–112. doi:10.1080/09540260902782752
   PubMed Web of Science ®Google Scholar
• Corchero, J., Fuentes, J. A., & Manzanares, J. (1999). Chronic treatment with CP-55,940 regulates corticotropin releasing factor and proopiomelanocortin gene expression in the hypothalamus and pituitary gland of the rat. Life Sciences, 64(11), 905–911. doi:10.1016/S0024-3205(99)00016-8
   PubMed Web of Science ®Google Scholar
• Corchero, J., Manzanares, J., & Fuentes, J. A. (2004). Cannabinoid/Opioid crosstalk in the central nervous system. Critical Reviews™ in Neurobiology, 16(1-2), 159–172. doi:10.1615/CritRevNeurobiol.v16.i12.170
   PubMedGoogle Scholar
• Cornelius, J. R., Aizenstein, H. J., & Hariri, A. R. (2010). Amygdala reactivity is inversely related to level of cannabis use in individuals with comorbid cannabis dependence and major depression. Addictive Behaviors, 35(6), 644–646. doi:10.1016/j.addbeh.2010.02.004
   PubMed Web of Science ®Google Scholar
• Cousijn, J., Wiers, R. W., Ridderinkhof, K. R., van den Brink, W., Veltman, D. J., & Goudriaan, A. E. (2012). Grey matter alterations associated with cannabis use: Results of a VBM study in heavy cannabis users and healthy controls. NeuroImage, 59(4), 3845–3851. doi:10.1016/j.neuroimage.2011.09.046
   PubMed Web of Science ®Google Scholar
• Crippa, J. A., Zuardi, A. W., Martin-Santos, R., Bhattacharyya, S., Atakan, Z., McGuire, P., & Fusar-Poli, P. (2009). Cannabis and anxiety: A critical review of the evidence. Human Psychopharmacology: Clinical and Experimental, 24(7), 515–523. doi:10.1002/hup.1048
   PubMed Web of Science ®Google Scholar
• Croll, S. D., Ip, N. Y., Lindsay, R. M., & Wiegand, S. J. (1998). Expression of BDNF and trkB as a function of age and cognitive performance. Brain Research, 812(1–2), 200–208. doi:10.1016/S0006-8993(98)00993-7
   PubMed Web of Science ®Google Scholar
• Cuttler, C., Mischley, L. K., & Sexton, M. (2016). Sex differences in cannabis use and effects: A cross-sectional survey of cannabis users. Cannabis and Cannabinoid Research, 1(1), 166–175. doi:10.1089/can.2016.0010
   PubMedGoogle Scholar
• Cuttler, C., Spradlin, A., Nusbaum, A. T., Whitney, P., Hinson, J. M., & McLaughlin, R. J. (2017). Blunted stress reactivity in chronic cannabis users. Psychopharmacology, 234(15), 2299–2309. doi:10.1007/s00213-017-4648-z
   PubMed Web of Science ®Google Scholar
• Dauer, W., & Przedborski, S. (2003). Parkinson's disease: Mechanisms and models. Neuron, 39(6), 889–909. doi:10.1016/S0896-6273(03)00568-3
   PubMed Web of Science ®Google Scholar
• Davies, S. N., Pertwee, R. G., & Riedel, G. (2002). Functions of cannabinoid receptors in the hippocampus. Neuropharmacology, 42(8), 993–1007. R doi:10.1016/S0028-3908(02)00060-6
   PubMed Web of Science ®Google Scholar
• De Fonseca, F. R., Gorriti, M., Fernandez-Ruiz, J., Palomo, T., & Ramos, J. (1994). Downregulation of rat brain cannabinoid binding sites after chronic Δ9-tetrahydrocannabinol treatment. Pharmacology Biochemistry and Behavior, 47(1), 33–40. doi:10.1016/0091-3057(94)90108-2
   PubMed Web of Science ®Google Scholar
• De Keyser, J., Ebinger, G., & Vauquelin, G. (1990). Age-related changes in the human nigrostriatal dopaminergic system. Annals of Neurology, 27(2), 157–161. doi:10.1002/ana.410270210
   PubMed Web of Science ®Google Scholar
• De Vries, T. J., Homberg, J. R., Binnekade, R., Raaso, H., & Schoffelmeer, A. N. M. (2003). Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats. Psychopharmacology, 168(1-2), 164–169. doi:10.1007/s00213-003-1422-1
   PubMed Web of Science ®Google Scholar
• Degenhardt, L., Hall, W., & Lynskey, M. (2001). The relationship between cannabis use and other substance use in the general population. Drug and Alcohol Dependence, 64(3), 319–327. doi:10.1016/S0376-8716(01)00130-2
   PubMed Web of Science ®Google Scholar
• Degenhardt, L., Hall, W., & Lynskey, M. (2003). Exploring the association between cannabis use and depression. Addiction, 98(11), 1493–1504. doi:10.1046/j.1360-0443.2003.00437.x
   PubMed Web of Science ®Google Scholar
• Degenhardt, L., Lintzeris, N., Campbell, G., Bruno, R., Cohen, M., Farrell, M., & Hall, W. D. (2015). Experience of adjunctive cannabis use for chronic non-cancer pain: Findings from the pain and opioids in treatment (point) study. Drug and Alcohol Dependence, 147, 144–150. doi:10.1016/j.drugalcdep.2014.11.031
   PubMed Web of Science ®Google Scholar
• Degroot, A., & Nomikos, G. G. (2007). In vivo neurochemical effects induced by changes in endocannabinoid neurotransmission. Current Opinion in Pharmacology, 7(1), 62–68. doi:10.1016/j.coph.2006.11.001
   PubMed Web of Science ®Google Scholar
• Degroot, A., Köfalvi, A., Wade, M. R., Davis, R. J., Rodrigues, R. J., Rebola, N., … Nomikos, G. G. (2006). CB1 receptor antagonism increases hippocampal acetylcholine release: Site and mechanism of action. Molecular Pharmacology, 70(4), 1236–1245. doi:10.1124/mol.106.024661
   PubMed Web of Science ®Google Scholar
• Demirakca, T., Sartorius, A., Ende, G., Meyer, N., Welzel, H., Skopp, G., … Hermann, D. (2011). Diminished gray matter in the hippocampus of cannabis users: Possible protective effects of cannabidiol. Drug and Alcohol Dependence, 114(2-3), 242–245. doi:10.1016/j.drugalcdep.2010.09.020
   PubMed Web of Science ®Google Scholar
• Dennis, N. A., Daselaar, S., & Cabeza, R. (2007). Effects of aging on transient and sustained successful memory encoding activity. Neurobiology of Aging, 28(11), 1749–1758. doi:10.1016/j.neurobiolaging.2006.07.006
   PubMed Web of Science ®Google Scholar
• Devane, W. A., Dysarz, F. A., 3rd, Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988). Determination and characterization of a cannabinoid receptor in rat brain. Molecular Pharmacology, 34(5), 605–613. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/2848184
   PubMed Web of Science ®Google Scholar
• Diana, M., Melis, M., Muntoni, A. L., & Gessa, G. L. (1998). Mesolimbic dopaminergic decline after cannabinoid withdrawal. Proceedings of the National Academy of Sciences of Sciences, 95(17), 10269–10273. doi:10.1073/pnas.95.17.10269
   PubMed Web of Science ®Google Scholar
• Dolan, R. J., & Fletcher, P. C. (1997). Dissociating prefrontal and hippocampal function in episodic memory encoding. Nature, 388(6642), 582–585. doi:10.1038/41561
   PubMed Web of Science ®Google Scholar
• Douaud, G., Groves, A. R., Tamnes, C. K., Westlye, L. T., Duff, E. P., Engvig, A., … Johansen-Berg, H. (2014). A common brain network links development, aging, and vulnerability to disease. Proceedings of the National Academy of Sciences, 111(49), 17648–17653. doi:10.1073/pnas.1410378111
   PubMed Web of Science ®Google Scholar
• Dreher, J. C., Meyer-Lindenberg, A., Kohn, P., & Berman, K. F. (2008). Age-related changes in midbrain dopaminergic regulation of the human reward system. Proceedings of the National Academy of Sciences of Sciences, 105(39), 15106–15111. doi:10.1073/pnas.0802127105
   PubMed Web of Science ®Google Scholar
• Driscoll, I., Howard, S. R., Stone, J. C., Monfils, M. H., Tomanek, B., Brooks, W. M., & Sutherland, R. J. (2006). The aging hippocampus: A multi-level analysis in the rat. Neuroscience, 139(4), 1173–1185. doi:10.1016/j.neuroscience.2006.01.040
   PubMed Web of Science ®Google Scholar
• Drolet, G., Dumont, E. C., Gosselin, I., Kinkead, R., Laforest, S., & Trottier, J. F. (2001). Role of endogenous opioid system in the regulation of the stress response. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 25(4), 729–741. doi:10.1016/S0278-5846(01)00161-0
   PubMed Web of Science ®Google Scholar
• D’Souza, D. C., Cortes-Briones, J. A., Ranganathan, M., Thurnauer, H., Creatura, G., Surti, T., … Skosnik, P. D. (2016). Rapid changes in cannabinoid 1 receptor availability in cannabis-dependent male subjects after abstinence from cannabis. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 1(1), 60–67. doi:10.1016/j.bpsc.2015.09.008
   Google Scholar
• D’Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y. T., … Krystal, J. H. (2004). The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis. Neuropsychopharmacology, 29(8), 1558–1572. doi:10.1038/sj.npp.1300496
   PubMed Web of Science ®Google Scholar
• D’Souza, D. C., Pittman, B., Perry, E., & Simen, A. (2009). Preliminary evidence of cannabinoid effects on brain-derived neurotrophic factor (BDNF) levels in humans. Psychopharmacology, 202(4), 569–578. doi:10.1007/s00213-008-1333-2
   PubMed Web of Science ®Google Scholar
• ElBatsh, M. M., Moklas, M., Marsden, C., & Kendall, D. (2012). Antidepressant-like effects of Δ9-tetrahydrocannabinol and rimonabant in the olfactory bulbectomised rat model of depression. Pharmacology Biochemistry and Behavior, 102(2), 357–365. doi:10.1016/j.pbb.2012.05.009
   PubMed Web of Science ®Google Scholar
• El-Remessy, A. B., Al-Shabrawey, M., Khalifa, Y., Tsai, N. T., Caldwell, R. B., & Liou, G. I. (2006). Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes. The American Journal of Pathology, 168(1), 235–244. doi:10.2353/ajpath.2006.050500
   PubMed Web of Science ®Google Scholar
• ElSohly, M. A., Mehmedic, Z., Foster, S., Gon, C., Chandra, S., & Church, J. C. (2016). Changes in cannabis potency over the last 2 decades (1995–2014): Analysis of current data in the United States. Biological Psychiatry, 79(7), 613–619. doi:10.1016/j.biopsych.2016.01.004
   PubMed Web of Science ®Google Scholar
• Erkkinen, M. G., Kim, M. O., & Geschwind, M. D. (2018). Clinical neurology and epidemiology of the major neurodegenerative diseases. Cold Spring Harbor Perspectives in Biology, 10(4), a033118. doi:10.1101/cshperspect.a033118
   PubMed Web of Science ®Google Scholar
• Espejo-Porras, F., Garcia-Toscano, L., Rodriguez-Cueto, C., Santos-Garcia, I., de Lago, E., & Fernandez-Ruiz, J. (2019). Targeting glial cannabinoid CB2 receptors to delay the progression of the pathological phenotype in TDP-43 (A315T) transgenic mice, a model of amyotrophic lateral sclerosis. British Journal of Pharmacology, 176(10), 1585–1600. doi:10.1111/bph.14216
   PubMed Web of Science ®Google Scholar
• Espejo-Porras, F., Piscitelli, F., Verde, R., Ramos, J. A., Di Marzo, V., de Lago, E., & Fernández-Ruiz, J. (2015). Changes in the endocannabinoid signaling system in CNS structures of TDP-43 transgenic mice: Relevance for a neuroprotective therapy in TDP-43-related disorders. Journal of Neuroimmune Pharmacology, 10(2), 233–244. doi:10.1007/s11481-015-9602-4
   PubMed Web of Science ®Google Scholar
• Fagerström, K. O., & Schneider, N. G. (1989). Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. Journal of Behavioral Medicine, 12(2), 159–182.
   PubMed Web of Science ®Google Scholar
• Fan, N., Yang, H., Zhang, J., & Chen, C. (2010). Reduced expression of glutamate receptors and phosphorylation of CREB are responsible for in vivo Δ9‐THC exposure‐impaired hippocampal synaptic plasticity. Journal of Neurochemistry, 112(3), 691–702. doi:10.1111/j.1471-4159.2009.06489.x
   PubMed Web of Science ®Google Scholar
• Felder, C. C., & Glass, M. (1998). Cannabinoid receptors and their endogenous agonists. Annual Review of Pharmacology and Toxicology, 38(1), 179–200. doi:10.1146/annurev.pharmtox.38.1.179
   PubMedGoogle Scholar
• Ferreira, F. F., Ribeiro, F. F., Rodrigues, R. S., Sebastiao, A. M., & Xapelli, S. (2018). Brain-Derived neurotrophic factor (BDNF) role in cannabinoid-mediated neurogenesis. Frontiers in Cellular Neuroscience, 12, 441. doi:10.3389/fncel.2018.00441
   PubMed Web of Science ®Google Scholar
• Fields, H. L., Heinricher, M. M., & Mason, P. (1991). Neurotransmitters in nociceptive modulatory circuits. Annual Review of Neuroscience, 14(1), 219–245. doi:10.1146/annurev.ne.14.030191.001251
   PubMedGoogle Scholar
• Filbey, F. M., & Yezhuvath, U. (2013). Functional connectivity in inhibitory control networks and severity of cannabis use disorder. The American Journal of Drug and Alcohol Abuse, 39(6), 382–391. doi:10.3109/00952990.2013.841710
   PubMed Web of Science ®Google Scholar
• Filbey, F. M., Aslan, S., Calhoun, V. D., Spence, J. S., Damaraju, E., Caprihan, A., & Segall, J. (2014). Long-term effects of marijuana use on the brain. Proceedings of the National Academy of Sciences of the United States of America, 111(47), 16913–16918. doi:10.1073/pnas.1415297111
   PubMed Web of Science ®Google Scholar
• Filbey, F. M., Gohel, S., Prashad, S., & Biswal, B. B. (2018). Differential associations of combined vs. isolated cannabis and nicotine on brain resting state networks. Brain Structure and Function, 223(7), 3317–3326. doi:10.1007/s00429-018-1690-5
   PubMed Web of Science ®Google Scholar
• Filbey, F. M., McQueeny, T., Kadamangudi, S., Bice, C., & Ketcherside, A. (2015). Combined effects of marijuana and nicotine on memory performance and hippocampal volume. Behavioural Brain Research, 293, 46–53. doi:10.1016/j.bbr.2015.07.029
   PubMed Web of Science ®Google Scholar
• Finn, D. P., Jhaveri, M. D., Beckett, S. R., Roe, C. H., Kendall, D. A., Marsden, C. A., & Chapman, V. (2003). Effects of direct periaqueductal grey administration of a cannabinoid receptor agonist on nociceptive and aversive responses in rats. Neuropharmacology, 45(5), 594–604. doi:10.1016/S0028-3908(03)00235-1
   PubMed Web of Science ®Google Scholar
• Fishbein-Kaminietsky, M., Gafni, M., & Sarne, Y. (2014). Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage. Journal of Neuroscience Research, 92(12), 1669–1677. doi:10.1002/jnr.23452
   PubMed Web of Science ®Google Scholar
• Fjell, A. M., McEvoy, L., Holland, D., Dale, A. M., Walhovd, K. B., & Initiative, A. S D. N. (2014). What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus. Progress in Neurobiology, 117, 20–40. doi:10.1016/j.pneurobio.2014.02.004
   PubMed Web of Science ®Google Scholar
• Fjell, A. M., Sneve, M. H., Grydeland, H., Storsve, A. B., & Walhovd, K. B. (2016). The disconnected brain and executive function decline in aging. Cerebral Cortex, 27(3), 2303–2317.
   Web of Science ®Google Scholar
• Fjell, A. M., Westlye, L. T., Amlien, I., Espeseth, T., Reinvang, I., Raz, N., … Walhovd, K. B. (2009). High consistency of regional cortical thinning in aging across multiple samples. Cerebral Cortex, 19(9), 2001–2012. doi:10.1093/cercor/bhn232
   PubMed Web of Science ®Google Scholar
• Foster, T. C., & Kumar, A. (2007). Susceptibility to induction of long-term depression is associated with impaired memory in aged Fischer 344 rats. Neurobiology of Learning and Memory, 87(4), 522–535. doi:10.1016/j.nlm.2006.12.009
   PubMed Web of Science ®Google Scholar
• Fride, E. (2005). Endocannabinoids in the central nervous system: From neuronal networks to behavior. Current Drug Target-CNS & Neurological Disorders, 4(6), 633–642. doi:10.2174/156800705774933069
   PubMedGoogle Scholar
• Fujii, M., Sherchan, P., Soejima, Y., Hasegawa, Y., Flores, J., Doycheva, D., & Zhang, J. H. (2014). Cannabinoid receptor type 2 agonist attenuates apoptosis by activation of phosphorylated CREB-Bcl-2 pathway after subarachnoid hemorrhage in rats. Experimental Neurology, 261, 396–403. doi:10.1016/j.expneurol.2014.07.005
   PubMed Web of Science ®Google Scholar
• Fusar-Poli, P., Crippa, J. A., Bhattacharyya, S., Borgwardt, S. J., Allen, P., Martin-Santos, R., … McGuire, P. K. (2009). Distinct effects of Δ9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Archives of General Psychiatry, 66(1), 95–105. doi:10.1001/archgenpsychiatry.2008.519
   PubMed Web of Science ®Google Scholar
• Gage, F. H. (2002). Neurogenesis in the adult brain. The Journal of Neuroscience, 22(3), 612–613. doi:10.1523/JNEUROSCI.22-03-00612.2002
   PubMed Web of Science ®Google Scholar
• Gallen, C. L., Turner, G. R., Adnan, A., & D'Esposito, M. (2016). Reconfiguration of brain network architecture to support executive control in aging. Neurobiology of Aging, 44, 42–52. doi:10.1016/j.neurobiolaging.2016.04.003
   PubMed Web of Science ®Google Scholar
• Galve-Roperh, I., Aguado, T., Palazuelos, J., & Guzman, M. (2008). Mechanisms of control of neuron survival by the endocannabinoid system. Current Pharmaceutical Design, 14(23), 2279–2288. doi:10.2174/138161208785740117
   PubMed Web of Science ®Google Scholar
• Galve-Roperh, I., Chiurchiu, V., Diaz-Alonso, J., Bari, M., Guzman, M., & Maccarrone, M. (2013). Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation. Progress in Lipid Research, 52(4), 633–650. doi:10.1016/j.plipres.2013.05.004
   PubMed Web of Science ®Google Scholar
• Gambert, S. R., Garthwaite, T. L., Pontzer, C. H., & Hagen, T. C. (1980). Age-Related changes in central nervous system beta-endorphin and ACTH. Neuroendocrinology, 31(4), 252–255. doi:10.1159/000123083
   PubMed Web of Science ®Google Scholar
• Garcia-Arencibia, M., Gonzalez, S., de Lago, E., Ramos, J. A., Mechoulam, R., & Fernandez-Ruiz, J. (2007). Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: Importance of antioxidant and cannabinoid receptor-independent properties. Brain Research, 1134(1), 162–170. doi:10.1016/j.brainres.2006.11.063
   PubMed Web of Science ®Google Scholar
• Geinisman, Y., de Toledo‐Morrell, L., Morrell, F., Persina, I. S., & Rossi, M. (1992). Age‐related loss of axospinous synapses formed by two afferent systems in the rat dentate gyrus as revealed by the unbiased stereological dissector technique. Hippocampus, 2(4), 437–444. doi:10.1002/hipo.450020411
   PubMed Web of Science ®Google Scholar
• George, O., Le Moal, M., & Koob, G. F. (2012). Allostasis and addiction: Role of the dopamine and corticotropin-releasing factor systems. Physiology & Behavior, 106(1), 58–64. doi:10.1016/j.physbeh.2011.11.004
   PubMed Web of Science ®Google Scholar
• Ghosh, S., Reuveni, I., Zidan, S., Lamprecht, R., & Barkai, E. (2018). Learning-Induced modulation of the effect of endocannabinoids on inhibitory synaptic transmission. Journal of Neurophysiology, 119(2), 752–760. doi:10.1152/jn.00623.2017
   PubMed Web of Science ®Google Scholar
• Glass, M., Dragunow, M., & Faull, R. L. (1997). Cannabinoid receptors in the human brain: A detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience, 77(2), 299–318. doi:10.1016/S0306-4522(96)00428-9
   PubMed Web of Science ®Google Scholar
• Goeders, N. E. (2003). The impact of stress on addiction. European Neuropsychopharmacology, 13(6), 435–441. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/14636959
   PubMed Web of Science ®Google Scholar
• Gold, B. T., Powell, D. K., Xuan, L., Jicha, G. A., & Smith, C. D. (2010). Age-Related slowing of task switching is associated with decreased integrity of frontoparietal white matter. Neurobiology of Aging, 31(3), 512–522. doi:10.1016/j.neurobiolaging.2008.04.005
   PubMed Web of Science ®Google Scholar
• Goldstein, R. Z., & Volkow, N. D. (2011). Dysfunction of the prefrontal cortex in addiction: Neuroimaging findings and clinical implications. Nature Reviews Neuroscience, 12(11), 652–669. doi:10.1038/nrn3119
   PubMed Web of Science ®Google Scholar
• Golomb, J., de Leon, M. J., Kluger, A., George, A. E., Tarshish, C., & Ferris, S. H. (1993). Hippocampal atrophy in normal aging. An association with recent memory impairment. Archives of Neurology, 50(9), 967–973. doi:10.1001/archneur.1993.00540090066012
   PubMed Web of Science ®Google Scholar
• Golomb, J., Kluger, A., de Leon, M. J., Ferris, S. H., Mittelman, M., Cohen, J., & George, A. E. (1996). Hippocampal formation size predicts declining memory performance in normal aging. Neurology, 47(3), 810–813. doi:10.1212/WNL.47.3.810
   PubMed Web of Science ®Google Scholar
• Gonzalez, S., Cebeira, M., & Fernandez-Ruiz, J. (2005). Cannabinoid tolerance and dependence: A review of studies in laboratory animals. Pharmacology Biochemistry and Behavior, 81(2), 300–318. doi:10.1016/j.pbb.2005.01.028
   PubMed Web of Science ®Google Scholar
• Goodwin, R. D., Pacek, L. R., Copeland, J., Moeller, S. J., Dierker, L., Weinberger, A., … Hasin, D. S. (2018). Trends in daily cannabis use among cigarette smokers: United States, 2002–2014. American Journal of Public Health, 108(1), 137–142. doi:10.2105/AJPH.2017.304050
   PubMed Web of Science ®Google Scholar
• Goonawardena, A. V., Robinson, L., Hampson, R. E., & Riedel, G. (2010). Cannabinoid and cholinergic systems interact during performance of a short-term memory task in the rat. Learning & Memory, 17(10), 502–511. doi:10.1101/lm.1893710
   PubMed Web of Science ®Google Scholar
• Gopher, D., & Koriat, A. (1999). Attention and performance XVII: Cognitive regulation of performance: Interaction of theory and application. Cambridge, MA: MIT Press.
   Google Scholar
• Gorzalka, B. B., Hill, M. N., & Hillard, C. J. (2008). Regulation of endocannabinoid signaling by stress: Implications for stress-related affective disorders. Neuroscience & Biobehavioral Reviews, 32(6), 1152–1160. doi:10.1016/j.neubiorev.2008.03.004
   PubMed Web of Science ®Google Scholar
• Grady, C. (2012). The cognitive neuroscience of ageing. Nature Reviews Neuroscience, 13(7), 491–505. doi:10.1038/nrn3256
   PubMed Web of Science ®Google Scholar
• Grady, C. L. (2008). Cognitive neuroscience of aging. Annals of the New York Academy of Sciences, 1124(1), 127–144. doi:10.1196/annals.1440.009
   PubMed Web of Science ®Google Scholar
• Grady, C. L., Springer, M. V., Hongwanishkul, D., McIntosh, A. R., & Winocur, G. (2006). Age-related changes in brain activity across the adult lifespan. Journal of Cognitive Neuroscience, 18(2), 227–241. doi:10.1162/jocn.2006.18.2.227
   PubMed Web of Science ®Google Scholar
• Grant, I., Gonzalez, R., Carey, C. L., Natarajan, L., & Wolfson, T. (2003). Non-acute (residual) neurocognitive effects of cannabis use: A meta-analytic study. Journal of the International Neuropsychological Society, 9(5), 679–689. doi:10.1017/S1355617703950016
   PubMed Web of Science ®Google Scholar
• Green, D. R., Galluzzi, L., & Kroemer, G. (2011). Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science, 333(6046), 1109–1112. doi:10.1126/science.1201940
   PubMed Web of Science ®Google Scholar
• Gruber, S. A., Silveri, M. M., Dahlgren, M. K., & Yurgelun-Todd, D. (2011). Why so impulsive? White matter alterations are associated with impulsivity in chronic marijuana smokers. Experimental and Clinical Psychopharmacology, 19(3), 231–242. doi:10.1037/a0023034
   PubMed Web of Science ®Google Scholar
• Guindon, J., Desroches, J., Dani, M., & Beaulieu, P. (2007). Pre-emptive antinociceptive effects of a synthetic cannabinoid in a model of neuropathic pain. European Journal of Pharmacology, 568(1-3), 173–176. doi:10.1016/j.ejphar.2007.04.060
   PubMed Web of Science ®Google Scholar
• Gunning-Dixon, F. M., Brickman, A. M., Cheng, J. C., & Alexopoulos, G. S. (2009). Aging of cerebral white matter: A review of MRI findings. International Journal of Geriatric Psychiatry, 24(2), 109–117. doi:10.1002/gps.2087
   PubMed Web of Science ®Google Scholar
• Gutchess, A. H., Welsh, R. C., Hedden, T., Bangert, A., Minear, M., Liu, L. L., & Park, D. C. (2005). Aging and the neural correlates of successful picture encoding: Frontal activations compensate for decreased medial-temporal activity. Journal of Cognitive Neuroscience, 17(1), 84–96. doi:10.1162/0898929052880048
   PubMed Web of Science ®Google Scholar
• Hampson, A. J., Grimaldi, M., Axelrod, J., & Wink, D. (1998). Cannabidiol and (-)delta9-tetrahydrocannabinol are neuroprotective antioxidants. Proceedings of the National Academy of Sciences, 95(14), 8268–8273. doi:10.1073/pnas.95.14.8268
   PubMed Web of Science ®Google Scholar
• Han, B. H., Sherman, S., Mauro, P. M., Martins, S. S., Rotenberg, J., & Palamar, J. J. (2017). Demographic trends among older cannabis users in the United States, 2006–13. Addiction, 112(3), 516–525. doi:10.1111/add.13670
   PubMed Web of Science ®Google Scholar
• Haney, M. (2007). Opioid antagonism of cannabinoid effects: Differences between marijuana smokers and nonmarijuana smokers. Neuropsychopharmacology, 32(6), 1391–1403. doi:10.1038/sj.npp.1301243
   PubMed Web of Science ®Google Scholar
• Harding, I. H., Solowij, N., Harrison, B. J., Takagi, M., Lorenzetti, V., Lubman, D. I., … Yücel, M. (2012). Functional connectivity in brain networks underlying cognitive control in chronic cannabis users. Neuropsychopharmacology, 37(8), 1923–1933. doi:10.1038/npp.2012.39
   PubMed Web of Science ®Google Scholar
• Haring, M., Marsicano, G., Lutz, B., & Monory, K. (2007). Identification of the cannabinoid receptor type 1 in serotonergic cells of raphe nuclei in mice. Neuroscience, 146(3), 1212–1219. doi:10.1016/j.neuroscience.2007.02.021
   PubMed Web of Science ®Google Scholar
• Harkany, T., Mackie, K., & Doherty, P. (2008). Wiring and firing neuronal networks: Endocannabinoids take center stage. Current Opinion in Neurobiology, 18(3), 338–345. doi:10.1016/j.conb.2008.08.007
   PubMed Web of Science ®Google Scholar
• Hartman, R. L., & Huestis, M. A. (2013). Cannabis effects on driving skills. Clinical Chemistry, 59(3), 478–492. doi:10.1373/clinchem.2012.194381
   PubMed Web of Science ®Google Scholar
• Hasin, D. S. (2018). US epidemiology of cannabis use and associated problems. Neuropsychopharmacology, 43(1), 195–212. doi:10.1038/npp.2017.198
   PubMed Web of Science ®Google Scholar
• Hasin, D. S., Saha, T. D., Kerridge, B. T., Goldstein, R. B., Chou, S. P., Zhang, H., … Grant, B. F. (2015). Prevalence of marijuana use disorders in the United States between 2001–2002 and 2012–2013. JAMA Psychiatry, 72(12), 1235–1242. doi:10.1001/jamapsychiatry.2015.1858
   PubMed Web of Science ®Google Scholar
• Heifets, B. D., & Castillo, P. E. (2009). Endocannabinoid signaling and long-term synaptic plasticity. Annual Review of Physiology, 71(1), 283–306. doi:10.1146/annurev.physiol.010908.163149
   PubMedGoogle Scholar
• Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., … Kummer, M. P. (2015). Neuroinflammation in Alzheimer's disease. The Lancet Neurology, 14(4), 388–405. doi:10.1016/S1474-4422(15)70016-5
   PubMed Web of Science ®Google Scholar
• Heng, L., Beverley, J. A., Steiner, H., & Tseng, K. Y. (2011). Differential developmental trajectories for CB1 cannabinoid receptor expression in limbic/associative and sensorimotor cortical areas. Synapse, 65(4), 278–286. doi:10.1002/syn.20844
   PubMed Web of Science ®Google Scholar
• Hermann, D., & Schneider, M. (2012). Potential protective effects of cannabidiol on neuroanatomical alterations in cannabis users and psychosis: A critical review. Current Pharmaceutical Design, 18(32), 4897–4905. doi:10.2174/138161212802884825
   PubMed Web of Science ®Google Scholar
• Hess, G. D., Joseph, J. A., & Roth, G. S. (1981). Effect of age on sensitivity to pain and brain opiate receptors. Neurobiology of Aging, 2(1), 49–55. doi:10.1016/0197-4580(81)90059-2
   PubMed Web of Science ®Google Scholar
• Hill, M. N., & McEwen, B. S. (2010). Involvement of the endocannabinoid system in the neurobehavioural effects of stress and glucocorticoids. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 34(5), 791–797. doi:10.1016/j.pnpbp.2009.11.001
   PubMed Web of Science ®Google Scholar
• Hill, M. N., & Tasker, J. G. (2012). Endocannabinoid signaling, glucocorticoid-mediated negative feedback, and regulation of the hypothalamic-pituitary-adrenal axis. Neuroscience, 204, 5–16. doi:10.1016/j.neuroscience.2011.12.030
   PubMed Web of Science ®Google Scholar
• Hill, M. N., McLaughlin, R. J., Bingham, B., Shrestha, L., Lee, T. T. Y., Gray, J. M., … Viau, V. (2010). Endogenous cannabinoid signaling is essential for stress adaptation. Proceedings of the National Academy of Sciences, 107(20), 9406–9411. doi:10.1073/pnas.0914661107
   PubMed Web of Science ®Google Scholar
• Hill, M. N., Sun, J. C., Tse, M. T., & Gorzalka, B. B. (2006). Altered responsiveness of serotonin receptor subtypes following long-term cannabinoid treatment. The International Journal of Neuropsychopharmacology, 9(03), 277–286. doi:10.1017/S1461145705005651
   PubMedGoogle Scholar
• Hirsch, E. C., & Hunot, S. (2009). Neuroinflammation in Parkinson's disease: A target for neuroprotection? Lancet Neurology, 8(4), 382–397. doi:10.1016/S1474-4422(09)70062-6
   PubMed Web of Science ®Google Scholar
• Hirvonen, J., Goodwin, R. S., Li, C.-T., Terry, G. E., Zoghbi, S. S., Morse, C., … Innis, R. B. (2012). Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Molecular Psychiatry, 17(6), 642–649. doi:10.1038/mp.2011.82
   PubMed Web of Science ®Google Scholar
• Hoffman, A. F., Oz, M., Caulder, T., & Lupica, C. R. (2003). Functional tolerance and blockade of long-term depression at synapses in the nucleus accumbens after chronic cannabinoid exposure. The Journal of Neuroscience, 23(12), 4815–4820. doi:10.1523/JNEUROSCI.23-12-04815.2003
   PubMed Web of Science ®Google Scholar
• Hoffman, A. F., Oz, M., Yang, R., Lichtman, A. H., & Lupica, C. R. (2007). Opposing actions of chronic delta9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation. Learning & Memory, 14(1–2), 63–74. doi:10.1101/lm.439007
   PubMed Web of Science ®Google Scholar
• Hornykiewicz, O. (1974). The mechanisms of action of L-DOPA in Parkinson's disease. Life Sciences, 15(7), 1249–1259. doi:10.1016/0024-3205(74)90306-3
   PubMed Web of Science ®Google Scholar
• Hurd, Y. L., Michaelides, M., Miller, M. L., & Jutras-Aswad, D. (2014). Trajectory of adolescent cannabis use on addiction vulnerability. Neuropharmacology, 76, 416–424. doi:10.1016/j.neuropharm.2013.07.028
   PubMed Web of Science ®Google Scholar
• Ishibashi, K., Ishii, K., Oda, K., Kawasaki, K., Mizusawa, H., & Ishiwata, K. (2009). Regional analysis of age-related decline in dopamine transporters and dopamine D2-like receptors in human striatum. Synapse, 63(4), 282–290. doi:10.1002/syn.20603
   PubMed Web of Science ®Google Scholar
• Issa, A. M., Rowe, W., Gauthier, S., & Meaney, M. J. (1990). Hypothalamic-Pituitary-Adrenal activity in aged, cognitively impaired and cognitively unimpaired rats. The Journal of Neuroscience, 10(10), 3247–3254. doi:10.1523/JNEUROSCI.10-10-03247.1990
   PubMed Web of Science ®Google Scholar
• Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Feldman, H. H., Frisoni, G. B., … Dubois, B. (2016). A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology, 87(5), 539–547. doi:10.1212/WNL.0000000000002923
   PubMed Web of Science ®Google Scholar
• Jakabek, D., Yücel, M., Lorenzetti, V., & Solowij, N. (2016). An MRI study of white matter tract integrity in regular cannabis users: Effects of cannabis use and age. Psychopharmacology, 233(19-20), 3627–3637. doi:10.1007/s00213-016-4398-3
   PubMed Web of Science ®Google Scholar
• Jankowski, M. P., & Sesack, S. R. (2004). Prefrontal cortical projections to the rat dorsal raphe nucleus: Ultrastructural features and associations with serotonin and gamma-aminobutyric acid neurons. The Journal of Comparative Neurology, 468(4), 518–529. doi:10.1002/cne.10976
   PubMed Web of Science ®Google Scholar
• Jiang, W., Zhang, Y., Xiao, L., Van Cleemput, J., Ji, S.-P., Bai, G., & Zhang, X. (2005). Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic-and antidepressant-like effects. Journal of Clinical Investigation, 115(11), 3104–3116. doi:10.1172/JCI25509
   PubMed Web of Science ®Google Scholar
• Jimenez-Del-Rio, M., Daza-Restrepo, A., & Velez-Pardo, C. (2008). The cannabinoid CP55,940 prolongs survival and improves locomotor activity in drosophila melanogaster against Paraquat: Implications in Parkinson's Disease. Neuroscience Research, 61(4), 404–411. doi:10.1016/j.neures.2008.04.011
   PubMed Web of Science ®Google Scholar
• Kandel, E. R., Schwartz, J. H., & Jessell, T. M. (2000). Principles of neural science. New York: McGraw-Hill.
   Google Scholar
• Karrer, T. M., Josef, A. K., Mata, R., Morris, E. D., & Samanez-Larkin, G. R. (2017). Reduced dopamine receptors and transporters but not synthesis capacity in normal aging adults: A meta-analysis. Neurobiology of Aging, 57, 36–46. doi:10.1016/j.neurobiolaging.2017.05.006
   PubMed Web of Science ®Google Scholar
• Kaskie, B., Ayyagari, P., Milavetz, G., Shane, D., & Arora, K. (2017). The increasing use of cannabis among older Americans: A public health crisis or viable policy alternative? The Gerontologist, 57(6), 1166–1172. doi:10.1093/geront/gnw166
   PubMed Web of Science ®Google Scholar
• Kathmann, M., Flau, K., Redmer, A., Tränkle, C., & Schlicker, E. (2006). Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors. Naunyn-Schmiedeberg's Archives of Pharmacology, 372(5), 354–361. doi:10.1007/s00210-006-0033-x
   PubMed Web of Science ®Google Scholar
• Katoh-Semba, R., Semba, R., Takeuchi, I. K., & Kato, K. (1998). Age-related changes in levels of brain-derived neurotrophic factor in selected brain regions of rats, normal mice and senescence-accelerated mice: A comparison to those of nerve growth factor and neurotrophin-3. Neuroscience Research, 31(3), 227–234. doi:10.1016/S0168-0102(98)00040-6
   PubMed Web of Science ®Google Scholar
• Katona, I., & Freund, T. F. (2012). Multiple functions of endocannabinoid signaling in the brain. Annual Review of Neuroscience, 35(1), 529–558. doi:10.1146/annurev-neuro-062111-150420
   PubMedGoogle Scholar
• Keimpema, E., Hökfelt, T., Harkany, T., & Doherty, P. (2014). The molecular interplay between endocannabinoid and neurotrophin signals in the nervous system and beyond. European Journal of Neuroscience, 39(3), 334–343. doi:10.1111/ejn.12431
   PubMed Web of Science ®Google Scholar
• King, G. R., Ernst, T., Deng, W., Stenger, A., Gonzales, R. M., Nakama, H., & Chang, L. (2011). Altered brain activation during visuomotor integration in chronic active cannabis users: Relationship to cortisol levels. Journal of Neuroscience, 31(49), 17923–17931. doi:10.1523/JNEUROSCI.4148-11.2011
   PubMed Web of Science ®Google Scholar
• Kinney, J. W., Bemiller, S. M., Murtishaw, A. S., Leisgang, A. M., & Lamb, B. T. (2018). Inflammation as a central mechanism in Alzheimer's disease. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 4, 575–590. doi:10.1016/j.trci.2018.06.014
   PubMedGoogle Scholar
• Klein, C., Karanges, E., Spiro, A., Wong, A., Spencer, J., Huynh, T., … McGregor, I. S. (2011). Cannabidiol potentiates Δ 9-tetrahydrocannabinol (THC) behavioural effects and alters thc pharmacokinetics during acute and chronic treatment in adolescent rats. Psychopharmacology, 218(2), 443–457. doi:10.1007/s00213-011-2342-0
   PubMed Web of Science ®Google Scholar
• Kochman, L. J., dos Santos, A. A., Fornal, C. A., & Jacobs, B. L. (2006). Despite strong behavioral disruption, δ9-tetrahydrocannabinol does not affect cell proliferation in the adult mouse dentate gyrus. Brain Research, 1113(1), 86–93. doi:10.1016/j.brainres.2006.07.080
   PubMedGoogle Scholar
• Koenders, L., Lorenzetti, V., de Haan, L., Suo, C., Vingerhoets, W. A. M., van den Brink, W., … Cousijn, J. (2017). Longitudinal study of hippocampal volumes in heavy cannabis users. Journal of Psychopharmacology, 31(8), 1027–1034. doi:10.1177/0269881117718380
   PubMed Web of Science ®Google Scholar
• Kowal, S. L., Dall, T. M., Chakrabarti, R., Storm, M. V., & Jain, A. (2013). The current and projected economic burden of Parkinson's disease in the United States. Movement Disorders, 28(3), 311–318. doi:10.1002/mds.25292
   PubMed Web of Science ®Google Scholar
• Kuhn, H. G., Dickinson-Anson, H., & Gage, F. H. (1996). Neurogenesis in the dentate gyrus of the adult rat: Age-related decrease of neuronal progenitor proliferation. The Journal of Neuroscience, 16(6), 2027–2033. doi:10.1523/JNEUROSCI.16-06-02027.1996
   PubMed Web of Science ®Google Scholar
• Lang, A. E., & Obeso, J. A. (2004). Challenges in Parkinson's disease: Restoration of the nigrostriatal dopamine system is not enough. The Lancet Neurology, 3(5), 309–316. doi:10.1016/S1474-4422(04)00740-9
   PubMed Web of Science ®Google Scholar
• Lapchak, P. A., Araujo, D. M., Beck, K. D., Finch, C. E., Johnson, S. A., & Hefti, F. (1993). BDNF and TrkB mRNA expression in the hippocampal formation of aging rats. Neurobiology of Aging, 14(2), 121–126. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/8487914
   PubMed Web of Science ®Google Scholar
• Lastres-Becker, I., Molina-Holgado, F., Ramos, J. A., Mechoulam, R., & Fernandez-Ruiz, J. (2005). Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's disease. Neurobiology of Disease, 19(1–2), 96–107. doi:10.1016/j.nbd.2004.11.009
   PubMed Web of Science ®Google Scholar
• Le Merrer, J., Becker, J. A., Befort, K., & Kieffer, B. L. (2009). Reward processing by the opioid system in the brain. Physiological Reviews, 89(4), 1379–1412. doi:10.1152/physrev.00005.2009
   PubMed Web of Science ®Google Scholar
• Lemtiri-Chlieh, F., & Levine, E. S. (2010). BDNF evokes release of endogenous cannabinoids at layer 2/3 inhibitory synapses in the neocortex. Journal of Neurophysiology, 104(4), 1923–1932.
   PubMed Web of Science ®Google Scholar
• Levinson, D. F. (2006). The genetics of depression: A review. Biological Psychiatry, 60(2), 84–92. doi:10.1016/j.biopsych.2005.08.024
   PubMed Web of Science ®Google Scholar
• Liang, Y. C., Huang, C. C., & Hsu, K. S. (2007). The synthetic cannabinoids attenuate allodynia and hyperalgesia in a rat model of trigeminal neuropathic pain. Neuropharmacology, 53(1), 169–177. doi:10.1016/j.neuropharm.2007.04.019
   PubMed Web of Science ®Google Scholar
• Lichtman, A. H., Cook, S. A., & Martin, B. R. (1996). Investigation of brain sites mediating cannabinoid-induced antinociception in rats: Evidence supporting periaqueductal gray involvement. Journal of Pharmacology and Experimental Therapeutics, 276(2), 585–593. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/8632325
   PubMed Web of Science ®Google Scholar
• Lister, J. P., & Barnes, C. A. (2009). Neurobiological changes in the hippocampus during normative aging. Archives of Neurology, 66(7), 829–833. doi:10.1001/archneurol.2009.125
   PubMedGoogle Scholar
• Liu, P., Bilkey, D. K., Darlington, C. L., & Smith, P. F. (2003). Cannabinoid CB1 receptor protein expression in the rat hippocampus and entorhinal, perirhinal, postrhinal and temporal cortices: Regional variations and age-related changes. Brain Research, 979(1–2), 235–239. doi:10.1016/S0006-8993(03)02872-5
   PubMed Web of Science ®Google Scholar
• Lloyd, S. L., & Striley, C. W. (2018). Marijuana use among adults 50 years or older in the 21st century. Gerontology and Geriatric Medicine, 4, 233372141878166. doi:10.1177/2333721418781668
   Web of Science ®Google Scholar
• Lopez-Moreno, J., Lopez-Jimenez, A., Gorriti, M., & de Fonseca, F. R. (2010). Functional interactions between endogenous cannabinoid and opioid systems: Focus on alcohol, genetics and drug-addicted behaviors. Current Drug Targets, 11(4), 406–428. doi:10.2174/138945010790980312
   PubMed Web of Science ®Google Scholar
• Lorenzetti, V., Solowij, N., & Yucel, M. (2016). The role of cannabinoids in neuroanatomic alterations in cannabis users. Biological Psychiatry, 79(7), e17–e31. doi:10.1016/j.biopsych.2015.11.013
   PubMed Web of Science ®Google Scholar
• Lovinger, D. M., & Mathur, B. N. (2016). Endocannabinoid signaling in the striatum. In H. Steiner & K. Y. Tseng (Eds.), Handbook of basal ganglia structure and function (Vol. 24, 2nd ed., pp. 197–215). Amsterdam: Elsevier.
   Google Scholar
• Lu, T., Pan, Y., Kao, S. Y., Li, C., Kohane, I., Chan, J., & Yankner, B. A. (2004). Gene regulation and DNA damage in the ageing human brain. Nature, 429(6994), 883–891. doi:10.1038/nature02661
   PubMed Web of Science ®Google Scholar
• Luebke, J. I., Chang, Y. M., Moore, T. L., & Rosene, D. L. (2004). Normal aging results in decreased synaptic excitation and increased synaptic inhibition of layer 2/3 pyramidal cells in the monkey prefrontal cortex. Neuroscience, 125(1), 277–288. doi:10.1016/j.neuroscience.2004.01.035
   PubMed Web of Science ®Google Scholar
• Luine, V., Bowling, D., & Hearns, M. (1990). Spatial memory deficits in aged rats: Contributions of monoaminergic systems. Brain Research, 537(1–2), 271–278. doi:10.1016/0006-8993(90)90368-L
   PubMed Web of Science ®Google Scholar
• Luo, Y., Zhou, J., Li, M.-X., Wu, P.-F., Hu, Z.-L., Ni, L., … Wang, F. (2015). Reversal of aging-related emotional memory deficits by norepinephrine via regulating the stability of surface AMPA receptors. Aging Cell, 14(2), 170–179. doi:10.1111/acel.12282
   PubMed Web of Science ®Google Scholar
• Luongo, L., Maione, S., & Di Marzo, V. (2014). Endocannabinoids and neuropathic pain: Focus on neuron-glia and endocannabinoid-neurotrophin interactions. European Journal of Neuroscience, 39(3), 401–408. doi:10.1111/ejn.12440
   PubMed Web of Science ®Google Scholar
• Lupica, C. R., & Riegel, A. C. (2005). Endocannabinoid release from midbrain dopamine neurons: A potential substrate for cannabinoid receptor antagonist treatment of addiction. Neuropharmacology, 48(8), 1105–1116. doi:10.1016/j.neuropharm.2005.03.016
   PubMed Web of Science ®Google Scholar
• Lupien, S. J., de Leon, M., de Santi, S., Convit, A., Tarshish, C., Nair, N. P. V., … Meaney, M. J. (1998). Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nature Neuroscience, 1(1), 69–73. doi:10.1038/271
   PubMed Web of Science ®Google Scholar
• Lupien, S. J., McEwen, B. S., Gunnar, M. R., & Heim, C. (2009). Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nature Reviews Neuroscience, 10(6), 434–445. doi:10.1038/nrn2639
   PubMed Web of Science ®Google Scholar
• Lupien, S., Lecours, A. R., Schwartz, G., Sharma, S., Hauger, R. L., Meaney, M. J., & Nair, N. P. (1996). Longitudinal study of basal cortisol levels in healthy elderly subjects: Evidence for subgroups. Neurobiology of Aging, 17(1), 95–105. doi:10.1016/0197-4580(95)02005-5
   PubMed Web of Science ®Google Scholar
• Lutz, B., Marsicano, G., Maldonado, R., & Hillard, C. J. (2015). The endocannabinoid system in guarding against fear, anxiety and stress. Nature Reviews Neuroscience, 16(12), 705–718. doi:10.1038/nrn4036
   PubMed Web of Science ®Google Scholar
• Mabry, T. R., Gold, P. E., & McCarty, R. (1995). Age-related changes in plasma catecholamine responses to acute swim stress. Neurobiology of Learning and Memory, 63(3), 260–268. doi:10.1006/nlme.1995.1030
   PubMed Web of Science ®Google Scholar
• Maison, P., Walker, D. J., Walsh, F. S., Williams, G., & Doherty, P. (2009). BDNF regulates neuronal sensitivity to endocannabinoids. Neuroscience Letters, 467(2), 90–94. doi:10.1016/j.neulet.2009.10.011
   PubMed Web of Science ®Google Scholar
• Maldonado, R., & Valverde, O. (2003). Participation of the opioid system in cannabinoid-induced antinociception and emotional-like responses. European Neuropsychopharmacology, 13(6), 401–410. doi:10.1016/j.euroneuro.2003.08.001
   PubMed Web of Science ®Google Scholar
• Maldonado, R., Valverde, O., & Berrendero, F. (2006). Involvement of the endocannabinoid system in drug addiction. Trends in Neurosciences, 29(4), 225–232. doi:10.1016/j.tins.2006.01.008
   PubMed Web of Science ®Google Scholar
• Manganas, L. N., Zhang, X., Li, Y., Hazel, R. D., Smith, S. D., Wagshul, M. E., … Maletic-Savatic, M. (2007). Magnetic resonance spectroscopy identifies neural progenitor cells in the live human brain. Science, 318(5852), 980–985. doi:10.1126/science.1147851
   PubMed Web of Science ®Google Scholar
• Mansi, J. A., Laforest, S., & Drolet, G. (2002). Effect of stress exposure on the activation pattern of enkephalin-containing perikarya in the rat ventral medulla. Journal of Neurochemistry, 74(6), 2568–2575. doi:10.1046/j.1471-4159.2000.0742568.x
   Web of Science ®Google Scholar
• Marchalant, Y., Baranger, K., Wenk, G. L., Khrestchatisky, M., & Rivera, S. (2012). Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention? Journal of Neuroinflammation, 9(1), 10. doi:10.1186/1742-2094-9-10
   PubMedGoogle Scholar
• Martini, L., Waldhoer, M., Pusch, M., Kharazia, V., Fong, J., Lee, J. H., … Whistler, J. L. (2007). Ligand-induced down-regulation of the cannabinoid 1 receptor is mediated by the G-protein-coupled receptor-associated sorting protein GASP1. The FASEB Journal, 21(3), 802–811. doi:10.1096/fj.06-7132com
   PubMed Web of Science ®Google Scholar
• Martin-Moreno, A. M., Brera, B., Spuch, C., Carro, E., Garcia-Garcia, L., Delgado, M., … de Ceballos, M. L. (2012). Prolonged oral cannabinoid administration prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in Tg APP 2576 mice. Journal of Neuroinflammation, 9(1), 1–15. doi:10.1186/1742-2094-9-8
   PubMedGoogle Scholar
• Martin-Pena, A., Acebes, A., Rodriguez, J. R., Sorribes, A., de Polavieja, G. G., Fernandez-Funez, P., & Ferrus, A. (2006). Age-independent synaptogenesis by phosphoinositide 3 kinase. Journal of Neuroscience, 26(40), 10199–10208. doi:10.1523/JNEUROSCI.1223-06.2006
   PubMed Web of Science ®Google Scholar
• Mato, S., Chevaleyre, V., Robbe, D., Pazos, A., Castillo, P. E., & Manzoni, O. J. (2004). A single in-vivo exposure to Δ9THC blocks endocannabinoid-mediated synaptic plasticity. Nature Neuroscience, 7(6), 585–586. doi:10.1038/nn1251
   PubMed Web of Science ®Google Scholar
• Matochik, J. A., Eldreth, D. A., Cadet, J. L., & Bolla, K. I. (2005). Altered brain tissue composition in heavy marijuana users. Drug and Alcohol Dependence, 77(1), 23–30. doi:10.1016/j.drugalcdep.2004.06.011
   PubMed Web of Science ®Google Scholar
• Mattson, M. P., & Magnus, T. (2006). Ageing and neuronal vulnerability. Nature Reviews Neuroscience, 7(4), 278–294. doi:10.1038/nrn1886
   PubMed Web of Science ®Google Scholar
• Mayer, T. A., Matar, M. A., Kaplan, Z., Zohar, J., & Cohen, H. (2014). Blunting of the HPA-axis underlies the lack of preventive efficacy of early post-stressor single-dose delta-9-tetrahydrocannabinol (THC). Pharmacology Biochemistry and Behavior, 122, 307–318. doi:10.1016/j.pbb.2014.04.014
   PubMed Web of Science ®Google Scholar
• McDonald, J., Schleifer, L., Richards, J. B., & de Wit, H. (2003). Effects of THC on behavioral measures of impulsivity in humans. Neuropsychopharmacology, 28(7), 1356–1365. doi:10.1038/sj.npp.1300176
   PubMed Web of Science ®Google Scholar
• McLaughlin, R. J., Hill, M. N., & Gorzalka, B. B. (2009). Monoaminergic neurotransmission contributes to cannabinoid-induced activation of the hypothalamic-pituitary-adrenal axis. European Journal of Pharmacology, 624(1-3), 71–76. doi:10.1016/j.ejphar.2009.09.055
   PubMed Web of Science ®Google Scholar
• McNab, F., Leroux, G., Strand, F., Thorell, L., Bergman, S., & Klingberg, T. (2008). Common and unique components of inhibition and working memory: An fMRI, within-subjects investigation. Neuropsychologia, 46(11), 2668–2682. doi:10.1016/j.neuropsychologia.2008.04.023
   PubMed Web of Science ®Google Scholar
• Mei, Y., Jiang, C., Wan, Y., Lv, J., Jia, J., Wang, X., … Tong, Z. (2015). Aging-associated formaldehyde-induced norepinephrine deficiency contributes to age-related memory decline. Aging Cell, 14(4), 659–668. doi:10.1111/acel.12345
   PubMed Web of Science ®Google Scholar
• Melis, M., Pistis, M., Perra, S., Muntoni, A. L., Pillolla, G., & Gessa, G. L. (2004). Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. Journal of Neuroscience, 24(1), 53–62. doi:10.1523/JNEUROSCI.4503-03.2004
   PubMed Web of Science ®Google Scholar
• Meltzer, C. C., Smith, G., DeKosky, S. T., Pollock, B. G., Mathis, C. A., Moore, R. Y., … Reynolds, C. F. 3rd. (1998). Serotonin in aging, late-life depression, and Alzheimer's disease: The emerging role of functional imaging. Neuropsychopharmacology, 18(6), 407–430. doi:10.1016/S0893-133X(97)00194-2
   PubMed Web of Science ®Google Scholar
• Miller, E. K., & Cohen, J. D. (2001). An integrative theory of prefrontal cortex function. Annual Review of Neuroscience, 24(1), 167–202. doi:10.1146/annurev.neuro.24.1.167
   PubMed Web of Science ®Google Scholar
• Miller, S. L., Celone, K., DePeau, K., Diamond, E., Dickerson, B. C., Rentz, D., … Sperling, R. A. (2008). Age-related memory impairment associated with loss of parietal deactivation but preserved hippocampal activation. Proceedings of the National Academy of Sciences of Sciences, 105(6), 2181–2186. doi:10.1073/pnas.0706818105
   PubMed Web of Science ®Google Scholar
• Mishima, K., Egashira, N., Matsumoto, Y., Iwasaki, K., & Fujiwara, M. (2002). Involvement of reduced acetylcholine release in delta9-tetrahydrocannabinol-induced impairment of spatial memory in the 8-arm radial maze. Life Sciences, 72(4-5), 397–407. doi:10.1016/S0024-3205(02)02274-9
   PubMed Web of Science ®Google Scholar
• Mohlman, J., & Gorman, J. M. (2005). The role of executive functioning in CBT: A pilot study with anxious older adults. Behaviour Research and Therapy, 43(4), 447–465. doi:10.1016/j.brat.2004.03.007
   PubMed Web of Science ®Google Scholar
• Morena, M., Patel, S., Bains, J. S., & Hill, M. N. (2016). Neurobiological interactions between stress and the endocannabinoid system. Neuropsychopharmacology, 41(1), 80–102. doi:10.1038/npp.2015.166
   PubMed Web of Science ®Google Scholar
• Morgan, C. J., & Curran, H. V. (2008). Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis. The British Journal of Psychiatry, 192(4), 306–307. doi:10.1192/bjp.bp.107.046649
   PubMed Web of Science ®Google Scholar
• Morgan, C. J. A., Page, E., Schaefer, C., Chatten, K., Manocha, A., Gulati, S., … Leweke, F. M. (2013). Cerebrospinal fluid anandamide levels, cannabis use and psychotic-like symptoms. British Journal of Psychiatry, 202(5), 381–382. doi:10.1192/bjp.bp.112.121178
   PubMed Web of Science ®Google Scholar
• Morgan, C. J., Schafer, G., Freeman, T. P., & Curran, H. V. (2010). Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: Naturalistic study: Naturalistic study [Corrected]. British Journal of Psychiatry, 197(4), 285–290. doi:10.1192/bjp.bp.110.077503
   PubMed Web of Science ®Google Scholar
• Morilak, D. A., Barrera, G., Echevarria, D. J., Garcia, A. S., Hernandez, A., Ma, S., & Petre, C. O. (2005). Role of brain norepinephrine in the behavioral response to stress. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 29(8), 1214–1224. doi:10.1016/j.pnpbp.2005.08.007
   PubMed Web of Science ®Google Scholar
• Mukherjee, J., Christian, B. T., Dunigan, K. A., Shi, B., Narayanan, T. K., Satter, M., & Mantil, J. (2002). Brain imaging of 18F-fallypride in normal volunteers: Blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors. Synapse, 46(3), 170–188. doi:10.1002/syn.10128
   PubMed Web of Science ®Google Scholar
• Mulder, J., Aguado, T., Keimpema, E., Barabas, K., Ballester Rosado, C. J., Nguyen, L., … Harkany, T. (2008). Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning. Proceedings of the National Academy of Sciences of Sciences, 105(25), 8760–8765. doi:10.1073/pnas.0803545105
   PubMed Web of Science ®Google Scholar
• Muntoni, A. L., Pillolla, G., Melis, M., Perra, S., Gessa, G. L., & Pistis, M. (2006). Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons. European Journal of Neuroscience, 23(9), 2385–2394. doi:10.1111/j.1460-9568.2006.04759.x
   PubMed Web of Science ®Google Scholar
• Murchison, C. F., Zhang, X. Y., Zhang, W. P., Ouyang, M., Lee, A., & Thomas, S. A. (2004). A distinct role for norepinephrine in memory retrieval. Cell, 117(1), 131–143. doi:10.1016/S0092-8674(04)00259-4
   PubMed Web of Science ®Google Scholar
• Nagahara, A. H., Gill, T. M., Nicolle, M., & Gallagher, M. (1996). Alterations in opiate receptor binding in the hippocampus of aged long-evans rats. Brain Research, 707(1), 22–30. doi:10.1016/0006-8993(95)01211-7
   PubMed Web of Science ®Google Scholar
• Nandhagopal, R., Kuramoto, L., Schulzer, M., Mak, E., Cragg, J., McKenzie, J., … Stoessl, A. J. (2011). Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease. Brain, 134(11), 3290–3298. doi:10.1093/brain/awr233
   PubMedGoogle Scholar
• Nava, F., Carta, G., Battasi, A., & Gessa, G. (2000). D2 dopamine receptors enable Δ9‐tetrahydrocannabinol induced memory impairment and reduction of hippocampal extracellular acetylcholine concentration. British Journal of Pharmacology, 130(6), 1201–1210. doi:10.1038/sj.bjp.0703413
   PubMed Web of Science ®Google Scholar
• Nava, F., Carta, G., Colombo, G., & Gessa, G. (2001). Effects of chronic Δ9-tetrahydrocannabinol treatment on hippocampal extracellular acetylcholine concentration and alternation performance in the T-Maze. Neuropharmacology, 41(3), 392–399. doi:10.1016/S0028-3908(01)00075-2
   PubMed Web of Science ®Google Scholar
• Navarro, M., Carrera, M. R. A., Fratta, W., Valverde, O., Cossu, G., Fattore, L., … de Fonseca, F. R. (2001). Functional interaction between opioid and cannabinoid receptors in drug self-administration. The Journal of Neuroscience, 21(14), 5344–5350. doi:10.1523/JNEUROSCI.21-14-05344.2001
   PubMed Web of Science ®Google Scholar
• Nielsen, S., Sabioni, P., Trigo, J. M., Ware, M. A., Betz-Stablein, B. D., Murnion, B., … Le Foll, B. (2017). Opioid-sparing effect of cannabinoids: A systematic review and meta-analysis. Neuropsychopharmacology, 42(9), 1752–1765. doi:10.1038/npp.2017.51
   PubMed Web of Science ®Google Scholar
• Norris, C. M., Korol, D. L., & Foster, T. C. (1996). Increased susceptibility to induction of long-term depression and long-term potentiation reversal during aging. The Journal of Neuroscience, 16(17), 5382–5392. doi:10.1523/JNEUROSCI.16-17-05382.1996
   PubMed Web of Science ®Google Scholar
• Ohm, T. G., Busch, C., & Bohl, J. (1997). Unbiased estimation of neuronal numbers in the human nucleus coeruleus during aging. Neurobiology of Aging, 18(4), 393–399. doi:10.1016/S0197-4580(97)00034-1
   PubMed Web of Science ®Google Scholar
• Olariu, A., Cleaver, K. M., & Cameron, H. A. (2007). Decreased neurogenesis in aged rats results from loss of granule cell precursors without lengthening of the cell cycle. The Journal of Comparative Neurology, 501(4), 659–667. doi:10.1002/cne.21268
   PubMed Web of Science ®Google Scholar
• Oropeza, V. C., Page, M. E., & Van Bockstaele, E. J. (2005). Systemic administration of WIN 55,212-2 increases norepinephrine release in the rat frontal cortex. Brain Research, 1046(1-2), 45–54. doi:10.1016/j.brainres.2005.03.036
   PubMed Web of Science ®Google Scholar
• Orr, J. M., Paschall, C. J., & Banich, M. T. (2016). Recreational marijuana use impacts white matter integrity and subcortical (but not cortical) morphometry. NeuroImage: Clinical, 12, 47–56. doi:10.1016/j.nicl.2016.06.006
   PubMed Web of Science ®Google Scholar
• Ownby, R. L. (2010). Neuroinflammation and cognitive aging. Current Psychiatry Reports, 12(1), 39–45. doi:10.1007/s11920-009-0082-1
   PubMed Web of Science ®Google Scholar
• Oz, M., Al Kury, L., Keun-Hang, S. Y., Mahgoub, M., & Galadari, S. (2014). Cellular approaches to the interaction between cannabinoid receptor ligands and nicotinic acetylcholine receptors. European Journal of Pharmacology, 731, 100–105. doi:10.1016/j.ejphar.2014.03.010
   PubMed Web of Science ®Google Scholar
• Pacek, L. R., Mauro, P. M., & Martins, S. S. (2015). Perceived risk of regular cannabis use in the United States from 2002 to 2012: Differences by sex, age, and race/ethnicity. Drug and Alcohol Dependence, 149, 232–244. doi:10.1016/j.drugalcdep.2015.02.009
   PubMed Web of Science ®Google Scholar
• Page, M. E., Oropeza, V. C., & Van Bockstaele, E. J. (2008). Local administration of a cannabinoid agonist alters norepinephrine efflux in the rat frontal cortex. Neuroscience Letters, 431(1), 1–5. doi:10.1016/j.neulet.2007.11.009
   PubMed Web of Science ®Google Scholar
• Palazuelos, J., Aguado, T., Egia, A., Mechoulam, R., Guzman, M., & Galve-Roperh, I. (2006). Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation. The FASEB Journal, 20(13), 2405–2407. doi:10.1096/fj.06-6164fje
   PubMed Web of Science ®Google Scholar
• Palazuelos, J., Ortega, Z., Diaz-Alonso, J., Guzman, M., & Galve-Roperh, I. (2012). CB2 cannabinoid receptors promote neural progenitor cell proliferation via mTORC1 signaling. Journal of Biological Chemistry, 287(2), 1198–1209. doi:10.1074/jbc.M111.291294
   PubMed Web of Science ®Google Scholar
• Park, D. C., & Reuter-Lorenz, P. (2009). The adaptive brain: Aging and neurocognitive scaffolding. Annual Review of Psychology, 60(1), 173–196. doi:10.1146/annurev.psych.59.103006.093656
   PubMed Web of Science ®Google Scholar
• Park, H., & Poo, M. M. (2013). Neurotrophin regulation of neural circuit development and function. Nature Reviews Neuroscience, 14(1), 7–23. doi:10.1038/nrn3379
   PubMed Web of Science ®Google Scholar
• Paronis, C. A., Nikas, S. P., Shukla, V. G., & Makriyannis, A. (2012). Δ9-Tetrahydrocannabinol acts as a partial agonist/antagonist in mice. Behavioural Pharmacology, 23(8), 802. doi:10.1097/FBP.0b013e32835a7c4d
   PubMed Web of Science ®Google Scholar
• Patel, S., Roelke, C. T., Rademacher, D. J., & Hillard, C. J. (2005). Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling. European Journal of Neuroscience, 21(4), 1057–1069. doi:10.1111/j.1460-9568.2005.03916.x
   PubMed Web of Science ®Google Scholar
• Pazos, M. R., Nunez, E., Benito, C., Tolon, R. M., & Romero, J. (2005). Functional neuroanatomy of the endocannabinoid system. Pharmacology Biochemistry and Behavior, 81(2), 239–247. doi:10.1016/j.pbb.2005.01.030
   PubMed Web of Science ®Google Scholar
• Pedersen, W. A., Wan, R., & Mattson, M. P. (2001). Impact of aging on stress-responsive neuroendocrine systems. Mechanisms of Ageing and Development, 122(9), 963–983. doi:10.1016/S0047-6374(01)00250-0
   PubMed Web of Science ®Google Scholar
• Persson, J., Nyberg, L., Lind, J., Larsson, A., Nilsson, L. G., Ingvar, M., & Buckner, R. L. (2006). Structure-function correlates of cognitive decline in aging. Cerebral Cortex, 16(7), 907–915. doi:10.1093/cercor/bhj036
   PubMed Web of Science ®Google Scholar
• Persson, J., Pudas, S., Lind, J., Kauppi, K., Nilsson, L. G., & Nyberg, L. (2012). Longitudinal structure-function correlates in elderly reveal MTL dysfunction with cognitive decline. Cerebral Cortex, 22(10), 2297–2304. doi:10.1093/cercor/bhr306
   PubMed Web of Science ®Google Scholar
• Pertwee, R. G. (2006). Cannabinoid pharmacology: The first 66 years. British Journal of Pharmacology, 147(S1), S163–S171. doi:10.1038/sj.bjp.0706406
   PubMedGoogle Scholar
• Pertwee, R. G. (2006). The pharmacology of cannabinoid receptors and their ligands: An overview. International Journal of Obesity, 30(S1), S13. doi:10.1038/sj.ijo.0803272
   Google Scholar
• Pertwee, R. G. (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. British Journal of Pharmacology, 153(2), 199–215. doi:10.1038/sj.bjp.0707442
   PubMed Web of Science ®Google Scholar
• Peskind, E. R., Wingerson, D., Murray, S., Pascualy, M., Dobie, D. J., Le Corre, P., … Raskind, M. A. (1995). Effects of Alzheimer's disease and normal aging on cerebrospinal fluid norepinephrine responses to yohimbine and clonidine. Archives of General Psychiatry, 52(9), 774–782. doi:10.1001/archpsyc.1995.03950210068012
   PubMed Web of Science ®Google Scholar
• Peters, A., Sethares, C., & Luebke, J. I. (2008). Synapses are lost during aging in the primate prefrontal cortex. Neuroscience, 152(4), 970–981. doi:10.1016/j.neuroscience.2007.07.014
   PubMed Web of Science ®Google Scholar
• Peters, R. (2006). Ageing and the brain. Postgraduate Medical Journal, 82(964), 84–88. doi:10.1136/pgmj.2005.036665
   PubMed Web of Science ®Google Scholar
• Petkov, V. D., Petkov, V. V., & Stancheva, S. L. (1988). Age-related changes in brain neurotransmission. Gerontology, 34(1-2), 14–21. doi:10.1159/000212925
   PubMed Web of Science ®Google Scholar
• Petralia, R. S., Mattson, M. P., & Yao, P. J. (2014). Communication breakdown: The impact of ageing on synapse structure. Ageing Research Reviews, 14, 31–42. doi:10.1016/j.arr.2014.01.003
   PubMed Web of Science ®Google Scholar
• Phelps, E. A., O'Connor, K. J., Gatenby, J. C., Gore, J. C., Grillon, C., & Davis, M. (2001). Activation of the left amygdala to a cognitive representation of fear. Nature Neuroscience, 4(4), 437–441. doi:10.1038/86110
   PubMed Web of Science ®Google Scholar
• Pickel, V. M., Chan, J., Kash, T. L., Rodriguez, J. J., & MacKie, K. (2004). Compartment-specific localization of cannabinoid 1 (CB1) and mu-opioid receptors in rat nucleus accumbens. Neuroscience, 127(1), 101–112. doi:10.1016/j.neuroscience.2004.05.015
   PubMed Web of Science ®Google Scholar
• Pisanu, A., Acquas, E., Fenu, S., & Di Chiara, G. (2006). Modulation of Δ9-THC-induced increase of cortical and hippocampal acetylcholine release by μ opioid and D1 dopamine receptors. Neuropharmacology, 50(6), 661–670. doi:10.1016/j.neuropharm.2005.11.023
   PubMed Web of Science ®Google Scholar
• Plassman, B. L., Langa, K. M., Fisher, G. G., Heeringa, S. G., Weir, D. R., Ofstedal, M. B., … Wallace, R. B. (2007). Prevalence of dementia in the United States: The aging, demographics, and memory study. Neuroepidemiology, 29(1-2), 125–132. doi:10.1159/000109998
   PubMed Web of Science ®Google Scholar
• Prenderville, J. A., Kelly, A. M., & Downer, E. J. (2015). The role of cannabinoids in adult neurogenesis. British Journal of Pharmacology, 172(16), 3950–3963. doi:10.1111/bph.13186
   PubMed Web of Science ®Google Scholar
• Przybyslawski, J., Roullet, P., & Sara, S. J. (1999). Attenuation of emotional and nonemotional memories after their reactivation: Role of β adrenergic receptors. The Journal of Neuroscience, 19(15), 6623–6628. doi:10.1523/JNEUROSCI.19-15-06623.1999
   PubMed Web of Science ®Google Scholar
• Pugh, G., Jr., Smith, P. B., Dombrowski, D. S., & Welch, S. P. (1996). The role of endogenous opioids in enhancing the antinociception produced by the combination of delta 9-tetrahydrocannabinol and morphine in the spinal cord. Journal of Pharmacology and Experimental Therapeutics, 279(2), 608–616. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/8930163.
   PubMed Web of Science ®Google Scholar
• Ramaekers, J. G., Moeller, M., van Ruitenbeek, P., Theunissen, E. L., Schneider, E., & Kauert, G. (2006). Cognition and motor control as a function of Δ9-THC concentration in serum and oral fluid: Limits of impairment. Drug and Alcohol Dependence, 85(2), 114–122. doi:10.1016/j.drugalcdep.2006.03.015
   PubMed Web of Science ®Google Scholar
• Ramirez, B. G., Blazquez, C., Gomez del Pulgar, T., Guzman, M., & de Ceballos, M. L. (2005). Prevention of Alzheimer's disease pathology by cannabinoids: Neuroprotection mediated by blockade of microglial activation. Journal of Neuroscience, 25(8), 1904–1913. doi:10.1523/JNEUROSCI.4540-04.2005
   PubMed Web of Science ®Google Scholar
• Ranganathan, M., Braley, G., Pittman, B., Cooper, T., Perry, E., Krystal, J., & D’Souza, D. C. (2009). The effects of cannabinoids on serum cortisol and prolactin in humans. Psychopharmacology, 203(4), 737–744. doi:10.1007/s00213-008-1422-2
   PubMed Web of Science ®Google Scholar
• Ratnavalli, E., Brayne, C., Dawson, K., & Hodges, J. R. (2002). The prevalence of frontotemporal dementia. Neurology, 58(11), 1615–1621. doi:10.1212/WNL.58.11.1615
   PubMed Web of Science ®Google Scholar
• Raz, N., Gunning, F. M., Head, D., Dupuis, J. H., McQuain, J., Briggs, S. D., … Acker, J. D. (1997). Selective aging of the human cerebral cortex observed in vivo: Differential vulnerability of the prefrontal gray matter. Cerebral Cortex, 7(3), 268–282. doi:10.1093/cercor/7.3.268
   PubMed Web of Science ®Google Scholar
• Raz, N., Rodrigue, K. M., Head, D., Kennedy, K. M., & Acker, J. D. (2004). Differential aging of the medial temporal lobe: A study of a five-year change. Neurology, 62(3), 433–438. doi:10.1212/01.WNL.0000106466.09835.46
   PubMed Web of Science ®Google Scholar
• Reitz, C., Brayne, C., & Mayeux, R. (2011). Epidemiology of Alzheimer disease. Nature Reviews Neurology, 7(3), 137–152. doi:10.1038/nrneurol.2011.2
   PubMed Web of Science ®Google Scholar
• Reyes, B. A., Szot, P., Sikkema, C., Cathel, A. M., Kirby, L. G., & Van Bockstaele, E. J. (2012). Stress-induced sensitization of cortical adrenergic receptors following a history of cannabinoid exposure. Experimental Neurology, 236(2), 327–335. doi:10.1016/j.expneurol.2012.05.016
   PubMed Web of Science ®Google Scholar
• Ribeiro, S. C., Kennedy, S. E., Smith, Y. R., Stohler, C. S., & Zubieta, J.-K. (2005). Interface of physical and emotional stress regulation through the endogenous opioid system and μ-opioid receptors. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 29(8), 1264–1280. doi:10.1016/j.pnpbp.2005.08.011
   PubMed Web of Science ®Google Scholar
• Rios, C., Gomes, I., & Devi, L. A. (2009). Mu opioid and CB1 cannabinoid receptor interactions: Reciprocal inhibition of receptor signaling and neuritogenesis. British Journal of Pharmacology, 148(4), 387–395. doi:10.1038/sj.bjp.0706757
   Google Scholar
• Robbe, D., Alonso, G., Duchamp, F., Bockaert, J., & Manzoni, O. J. (2001). Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. The Journal of Neuroscience, 21(1), 109–116. doi:10.1523/JNEUROSCI.21-01-00109.2001
   PubMed Web of Science ®Google Scholar
• Robinson, L., Goonawardena, A. V., Pertwee, R., Hampson, R. E., Platt, B., & Riedel, G. (2010). WIN55,212-2 induced deficits in spatial learning are mediated by cholinergic hypofunction. Behavioural Brain Research, 208(2), 584–592. doi:10.1016/j.bbr.2010.01.004
   PubMed Web of Science ®Google Scholar
• Rocchetti, M., Crescini, A., Borgwardt, S., Caverzasi, E., Politi, P., Atakan, Z., & Fusar‐Poli, P. (2013). Is cannabis neurotoxic for the healthy brain? A meta‐analytical review of structural brain alterations in non‐psychotic users. Psychiatry and Clinical Neurosciences, 67(7), 483–492. doi:10.1111/pcn.12085
   PubMed Web of Science ®Google Scholar
• Roman, G. C. (2003). Vascular dementia: Distinguishing characteristics, treatment, and prevention. Journal of the American Geriatrics Society, 51(5 Suppl Dementia), S296–S304. doi:10.1046/j.1532-5415.5155.x
   PubMed Web of Science ®Google Scholar
• Romero, J., Berrendero, F., Garcia-Gil, L., De la Cruz, P., Ramos, J., & Fernandez-Ruiz, J. (1998). Loss of cannabinoid receptor binding and messenger RNA levels and cannabinoid agonist-stimulated [35s] guanylyl-5′-o-(thio)-triphosphate binding in the basal ganglia of aged rats. Neuroscience, 84(4), 1075–1083. doi:10.1016/S0306-4522(97)00552-6
   PubMed Web of Science ®Google Scholar
• Ross, G. W., Petrovitch, H., Abbott, R. D., Nelson, J., Markesbery, W., Davis, D., … White, L. R. (2004). Parkinsonian signs and substantia nigra neuron density in decendents elders without PD. Annals of Neurology, 56(4), 532–539. doi:10.1002/ana.20226
   PubMed Web of Science ®Google Scholar
• Rossi, C., Angelucci, A., Costantin, L., Braschi, C., Mazzantini, M., Babbini, F., … Caleo, M. (2006). Brain‐derived neurotrophic factor (BDNF) is required for the enhancement of hippocampal neurogenesis following environmental enrichment. European Journal of Neuroscience, 24(7), 1850–1856. doi:10.1111/j.1460-9568.2006.05059.x
   PubMed Web of Science ®Google Scholar
• Salas-Wright, C. P., Vaughn, M. G., Cummings-Vaughn, L. A., Holzer, K. J., Nelson, E. J., AbiNader, M., & Oh, S. (2017). Trends and correlates of marijuana use among late middle-aged and older adults in the United States, 2002–2014. Drug and Alcohol Dependence, 171, 97–106. doi:10.1016/j.drugalcdep.2016.11.031
   PubMed Web of Science ®Google Scholar
• Salat, D. H., Kaye, J. A., & Janowsky, J. S. (1999). Prefrontal gray and white matter volumes in healthy aging and Alzheimer disease. Archives of Neurology, 56(3), 338–344. doi:10.1001/archneur.56.3.338
   PubMedGoogle Scholar
• Salat, D. H., Kaye, J. A., & Janowsky, J. S. (2001). Selective preservation and degeneration within the prefrontal cortex in aging and Alzheimer disease. Archives of Neurology, 58(9), 1403–1408. doi:10.1001/archneur.58.9.1403
   PubMed Web of Science ®Google Scholar
• Salthouse, T. A. (2009). Decomposing age correlations on neuropsychological and cognitive variables. Journal of the International Neuropsychological Society, 15(5), 650–661. doi:10.1017/S1355617709990385
   PubMed Web of Science ®Google Scholar
• Sara, S. J. (2009). The locus coeruleus and noradrenergic modulation of cognition. Nature Reviews Neuroscience, 10(3), 211–223. doi:10.1038/nrn2573
   PubMed Web of Science ®Google Scholar
• Sarne, Y., Asaf, F., Fishbein, M., Gafni, M., & Keren, O. (2011). The dual neuroprotective-neurotoxic profile of cannabinoid drugs. British Journal of Pharmacology, 163(7), 1391–1401. doi:10.1111/j.1476-5381.2011.01280.x
   PubMed Web of Science ®Google Scholar
• Sarne, Y., Toledano, R., Rachmany, L., Sasson, E., & Doron, R. (2018). Reversal of age-related cognitive impairments in mice by an extremely low dose of tetrahydrocannabinol. Neurobiology of Aging, 61, 177–186. doi:10.1016/j.neurobiolaging.2017.09.025
   PubMed Web of Science ®Google Scholar
• Saunders, J. B., Aasland, O. G., Babor, T. F., De la Fuente, J. R., & Grant, M. (1993). Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption--II. Addiction, 88(6), 791–804.
   PubMed Web of Science ®Google Scholar
• Scavone, J. L., Mackie, K., & Van Bockstaele, E. J. (2010). Characterization of cannabinoid-1 receptors in the locus coeruleus: Relationship with mu-opioid receptors. Brain Research, 1312, 18–31. doi:10.1016/j.brainres.2009.11.023
   PubMed Web of Science ®Google Scholar
• Scavone, J. L., Sterling, R. C., & Van Bockstaele, E. J. (2013). Cannabinoid and opioid interactions: Implications for opiate dependence and withdrawal. Neuroscience, 248, 637–654. doi:10.1016/j.neuroscience.2013.04.034
   PubMed Web of Science ®Google Scholar
• Schiavon, A. P., Soares, L. M., Bonato, J. M., Milani, H., Guimaraes, F. S., & Weffort de Oliveira, R. M. (2014). Protective effects of cannabidiol against hippocampal cell death and cognitive impairment induced by bilateral common carotid artery occlusion in mice. Neurotoxicity Research, 26(4), 307–316. doi:10.1007/s12640-014-9457-0
   PubMed Web of Science ®Google Scholar
• Schliebs, R., & Arendt, T. (2011). The cholinergic system in aging and neuronal degeneration. Behavioural Brain Research, 221(2), 555–563. doi:10.1016/j.bbr.2010.11.058
   PubMed Web of Science ®Google Scholar
• Schoffelmeer, A., Hogenboom, F., Wardeh, G., & De Vries, T. (2006). Interactions between CB1 cannabinoid and μ opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core. Neuropharmacology, 51(4), 773–781. doi:10.1016/j.neuropharm.2006.05.019
   PubMed Web of Science ®Google Scholar
• Schuitemaker, A., van der Doef, T. F., Boellaard, R., van der Flier, W. M., Yaqub, M., Windhorst, A. D., … van Berckel, B. N. M. (2012). Microglial activation in healthy aging. Neurobiology of Aging, 33(6), 1067–1072. doi:10.1016/j.neurobiolaging.2010.09.016
   PubMed Web of Science ®Google Scholar
• Schulze, E. T., Geary, E. K., Susmaras, T. M., Paliga, J. T., Maki, P. M., & Little, D. M. (2011). Anatomical correlates of age-related working memory declines. Journal of Aging Research, 2011, 1. doi:10.4061/2011/606871
   Google Scholar
• Schuster, R. M., Crane, N. A., Mermelstein, R., & Gonzalez, R. (2015). Tobacco may mask poorer episodic memory among young adult cannabis users. Neuropsychology, 29(5), 759. doi:10.1037/neu0000173
   PubMed Web of Science ®Google Scholar
• Seelaar, H., Rohrer, J. D., Pijnenburg, Y. A., Fox, N. C., & van Swieten, J. C. (2011). Clinical, genetic and pathological heterogeneity of frontotemporal dementia: A review. Journal of Neurology, Neurosurgery and Psychiatry, 82(5), 476–486. doi:10.1136/jnnp.2010.212225
   PubMed Web of Science ®Google Scholar
• Seeman, P., Bzowej, N. H., Guan, H.-C., Bergeron, C., Becker, L. E., Reynolds, G. P., … Tourtellotte, W. W. (1987). Human brain dopamine receptors in children and aging adults. Synapse, 1(5), 399–404. doi:10.1002/syn.890010503
   PubMed Web of Science ®Google Scholar
• Sherman, B. J., & McRae‐Clark, A. L. (2016). Treatment of cannabis use disorder: Current science and future outlook. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 36(5), 511–535. doi:10.1002/phar.1747
   Google Scholar
• Singh, M., Verty, A., McGregor, I., & Mallet, P. (2004). A cannabinoid receptor antagonist attenuates conditioned place preference but not behavioural sensitization to morphine. Brain Research, 1026(2), 244–253. doi:10.1016/j.brainres.2004.08.027
   PubMed Web of Science ®Google Scholar
• Slanina, K. A., Roberto, M., & Schweitzer, P. (2005). Endocannabinoids restrict hippocampal long-term potentiation via CB1. Neuropharmacology, 49(5), 660–668. doi:10.1016/j.neuropharm.2005.04.021
   PubMed Web of Science ®Google Scholar
• Smith, F. L., Cichewicz, D., Martin, Z. L., & Welch, S. P. (1998). The enhancement of morphine antinociception in mice by delta9-tetrahydrocannabinol. Pharmacology Biochemistry and Behavior, 60(2), 559–566. doi:10.1016/S0091-3057(98)00012-4
   PubMed Web of Science ®Google Scholar
• Sohal, R. S., & Weindruch, R. (1996). Oxidative stress, caloric restriction, and aging. Science, 273(5271), 59–63. doi:10.1126/science.273.5271.59
   PubMed Web of Science ®Google Scholar
• Solowij, N., & Battisti, R. (2008). The chronic effects of cannabis on memory in humans: A review. Current Drug Abuse Reviews, 1(1), 81–98.
   PubMedGoogle Scholar
• Somaini, L., Manfredini, M., Amore, M., Zaimovic, A., Raggi, M. A., Leonardi, C., … Gerra, G. (2012). Psychobiological responses to unpleasant emotions in cannabis users. European Archives of Psychiatry and Clinical Neuroscience, 262(1), 47–57. doi:10.1007/s00406-011-0223-5
   PubMed Web of Science ®Google Scholar
• Sosa-Ortiz, A. L., Acosta-Castillo, I., & Prince, M. J. (2012). Epidemiology of dementias and Alzheimer's disease. Archives of Medical Research, 43(8), 600–608. doi:10.1016/j.arcmed.2012.11.003
   PubMed Web of Science ®Google Scholar
• Stokes, P. R. A., Egerton, A., Watson, B., Reid, A., Breen, G., Lingford-Hughes, A., … Mehta, M. A. (2010). Significant decreases in frontal and temporal [11c]-raclopride binding after THC challenge. NeuroImage, 52(4), 1521–1527. doi:10.1016/j.neuroimage.2010.04.274
   PubMed Web of Science ®Google Scholar
• Stopponi, S., Soverchia, L., Ubaldi, M., Cippitelli, A., Serpelloni, G., & Ciccocioppo, R. (2014). Chronic THC during adolescence increases the vulnerability to stress-induced relapse to heroin seeking in adult rats. European Neuropsychopharmacology, 24(7), 1037–1045. doi:10.1016/j.euroneuro.2013.12.012
   PubMed Web of Science ®Google Scholar
• Subbanna, S., Shivakumar, M., Psychoyos, D., Xie, S., & Basavarajappa, B. S. (2013). Anandamide-CB1 receptor signaling contributes to postnatal ethanol-induced neonatal neurodegeneration, adult synaptic, and memory deficits. Journal of Neuroscience, 33(15), 6350–6366. doi:10.1523/JNEUROSCI.3786-12.2013
   PubMed Web of Science ®Google Scholar
• Subbaraman, M. S., & Kerr, W. C. (2015). Simultaneous versus concurrent use of alcohol and cannabis in the National Alcohol Survey. Alcoholism: Clinical and Experimental Research, 39(5), 872–879. doi:10.1111/acer.12698
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. (2016). 2015 National survey on drug use and health. Rockville, MD: Substance Abuse and Mental Health Services Administration.
   Google Scholar
• Sugarman, D., De Aquino, J., Poling, J., & Sofuoglu, M. (2019). Feasibility and effects of galantamine on cognition in humans with cannabis use disorder. Pharmacology Biochemistry and Behavior, 181, 86.
   PubMed Web of Science ®Google Scholar
• Suliman, N. A., Taib, C. N. M., Moklas, M. A. M., & Basir, R. (2018). Delta-9-tetrahydrocannabinol (Δ9-THC) induce neurogenesis and improve cognitive performances of male Sprague Dawley rats. Neurotoxicity Research, 33(2), 402–411. doi:10.1007/s12640-017-9806-x
   PubMed Web of Science ®Google Scholar
• Suridjan, I., Rusjan, P. M., Voineskos, A. N., Selvanathan, T., Setiawan, E., Strafella, A. P., … Mizrahi, R. (2014). Neuroinflammation in healthy aging: A PET study using a novel translocator protein 18 kDa (TSPO) radioligand, [18F]-FEPPA. NeuroImage, 84, 868–875. doi:10.1016/j.neuroimage.2013.09.021
   PubMed Web of Science ®Google Scholar
• Szenborn, M. (1993). Neuropathological study on the nucleus basalis of meynert in mature and old age. Patologia Polska, 44(4), 211–216. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/8309732
   PubMedGoogle Scholar
• Takeuchi, H., Taki, Y., Sassa, Y., Hashizume, H., Sekiguchi, A., Fukushima, A., & Kawashima, R. (2013). Brain structures associated with executive functions during everyday events in a non-clinical sample. Brain Structure and Function, 218(4), 1017–1032. doi:10.1007/s00429-012-0444-z
   PubMed Web of Science ®Google Scholar
• Thayer, R. E. (2018). Marijuana use in an aging population: Global brain structure and cognitive function (Doctoral dissertation). University of Colorado at Boulder.
   Google Scholar
• Theunissen, E. L., Heckman, P., de Sousa Fernandes Perna, E. B., Kuypers, K. P. C., Sambeth, A., Blokland, A., … Ramaekers, J. G. (2015). Rivastigmine but not vardenafil reverses cannabis-induced impairment of verbal memory in healthy humans. Psychopharmacology, 232(2), 343–353. doi:10.1007/s00213-014-3667-2
   PubMed Web of Science ®Google Scholar
• Tully, K., & Bolshakov, V. Y. (2010). Emotional enhancement of memory: How norepinephrine enables synaptic plasticity. Molecular Brain, 3(1), 15. doi:10.1186/1756-6606-3-15
   PubMedGoogle Scholar
• Turcotte, C., Blanchet, M.-R., Laviolette, M., & Flamand, N. (2016). The CB2 receptor and its role as a regulator of inflammation. Cellular and Molecular Life Sciences: CMLS, 73(23), 4449–4470. doi:10.1007/s00018-016-2300-4
   PubMed Web of Science ®Google Scholar
• Tzavara, E. T., Wade, M., & Nomikos, G. G. (2003). Biphasic effects of cannabinoids on acetylcholine release in the hippocampus: Site and mechanism of action. The Journal of Neuroscience, 23(28), 9374–9384. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/14561865 doi:10.1523/JNEUROSCI.23-28-09374.2003
   PubMed Web of Science ®Google Scholar
• Tzilos, G. K., Cintron, C. B., Wood, J. B., Simpson, N. S., Young, A. D., Pope, H. G., Jr., & Yurgelun-Todd, D. A. (2005). Lack of hippocampal volume change in long-term heavy cannabis users. American Journal on Addictions, 14(1), 64–72. doi:10.1080/10550490590899862
   PubMed Web of Science ®Google Scholar
• Van Laere, K., Goffin, K., Casteels, C., Dupont, P., Mortelmans, L., de Hoon, J., & Bormans, G. (2008). Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [18F] MK-9470 PET. Neuroimage, 39(4), 1533–1541.
   PubMed Web of Science ®Google Scholar
• van Vliet, S. A., Vanwersch, R. A., Jongsma, M. J., Olivier, B., & Philippens, I. H. (2008). Therapeutic effects of delta9-THC and modafinil in a marmoset Parkinson model. European Neuropsychopharmacology, 18(5), 383–389. doi:10.1016/j.euroneuro.2007.11.003
   PubMed Web of Science ®Google Scholar
• Varvel, S. A., Hamm, R. J., Martin, B. R., & Lichtman, A. H. (2001). Differential effects of delta 9-THC on spatial reference and working memory in mice. Psychopharmacology, 157(2), 142–150. doi:10.1007/s002130100780
   PubMed Web of Science ®Google Scholar
• Villares, J. (2007). Chronic use of marijuana decreases cannabinoid receptor binding and mRNA expression in the human brain. Neuroscience, 145(1), 323–334. doi:10.1016/j.neuroscience.2006.11.012
   PubMed Web of Science ®Google Scholar
• Volkow, N. D., Baler, R. D., Compton, W. M., & Weiss, S. R. (2014). Adverse health effects of marijuana use. The New England Journal of Medicine, 370(23), 2219–2227. doi:10.1056/NEJMra1402309
   PubMed Web of Science ®Google Scholar
• Volkow, N. D., Fowler, J. S., Wang, G. J., Logan, J., Schlyer, D., MacGregor, R., … Wolf, A. P. (1994). Decreased dopamine transporters with age in healthy human subjects. Annals of Neurology, 36(2), 237–239. doi:10.1002/ana.410360218
   PubMed Web of Science ®Google Scholar
• Volkow, N. D., Wang, G. J., Fowler, J. S., Tomasi, D., & Telang, F. (2011). Addiction: Beyond dopamine reward circuitry. Proceedings of the National Academy of Sciences of Sciences, 108(37), 15037–15042. doi:10.1073/pnas.1010654108
   PubMed Web of Science ®Google Scholar
• Voon, V., Mehta, A. R., & Hallett, M. (2011). Impulse control disorders in Parkinson's disease: Recent advances. Current Opinion in Neurology, 24(4), 324–330. doi:10.1097/WCO.0b013e3283489687
   PubMed Web of Science ®Google Scholar
• Wagner, F. A., & Anthony, J. C. (2002). From first drug use to drug dependence: Developmental periods of risk for dependence upon marijuana, cocaine, and alcohol. Neuropsychopharmacology, 26(4), 479–488. doi:10.1016/S0893-133X(01)00367-0
   PubMed Web of Science ®Google Scholar
• Wang, D. P., Yin, H., Kang, K., Lin, Q., Su, S. H., & Hai, J. (2018). The potential protective effects of cannabinoid receptor agonist WIN55, 212-2 on cognitive dysfunction is associated with the suppression of autophagy and inflammation in an experimental model of vascular dementia. Psychiatry Research, 267, 281–288. doi:10.1016/j.psychres.2018.06.012
   PubMed Web of Science ®Google Scholar
• Wang, L., Liu, J., Harvey-White, J., Zimmer, A., & Kunos, G. (2003). Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proceedings of the National Academy of Sciences, 100(3), 1393–1398. doi:10.1073/pnas.0336351100
   PubMed Web of Science ®Google Scholar
• Ware, M. A., Wang, T., Shapiro, S., Robinson, A., Ducruet, T., Huynh, T., … Collet, J.-P. (2010). Smoked cannabis for chronic neuropathic pain: A randomized controlled trial. Canadian Medical Association Journal, 182(14), E694–701. doi:10.1503/cmaj.091414
   PubMed Web of Science ®Google Scholar
• Weintraub, D., Koester, J., Potenza, M. N., Siderowf, A. D., Stacy, M., Voon, V., … Lang, A. E. (2010). Impulse control disorders in Parkinson disease: A cross-sectional study of 3090 patients. Archives of Neurology, 67(5), 589–595. doi:10.1001/archneurol.2010.65
   PubMed Web of Science ®Google Scholar
• West, M. J. (1993). Regionally specific loss of neurons in the aging human hippocampus. Neurobiology of Aging, 14(4), 287–293. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/8367010 doi:10.1016/0197-4580(93)90113-P
   PubMed Web of Science ®Google Scholar
• Wilkins, H., & Swerdlow, R. (2016). Relationships between mitochondria and neuroinflammation: Implications for Alzheimer’s disease. Current Topics in Medicinal Chemistry, 16(8), 849–857.
   PubMed Web of Science ®Google Scholar
• Wilson-Poe, A., Morgan, M., Aicher, S., & Hegarty, D. (2012). Distribution of CB1 cannabinoid receptors and their relationship with mu-opioid receptors in the rat periaqueductal gray. Neuroscience, 213, 191–200. doi:10.1016/j.neuroscience.2012.03.038
   PubMed Web of Science ®Google Scholar
• Wilson-Poe, A., Pocius, E., Herschbach, M., & Morgan, M. (2013). The periaqueductal gray contributes to bidirectional enhancement of antinociception between morphine and cannabinoids. Pharmacology Biochemistry and Behavior, 103(3), 444–449. doi:10.1016/j.pbb.2012.10.002
   PubMed Web of Science ®Google Scholar
• Winton-Brown, T. T., Allen, P., Bhattacharrya, S., Borgwardt, S. J., Fusar-Poli, P., Crippa, J. A., … McGuire, P. K. (2011). Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: An fMRI study. Neuropsychopharmacology, 36(7), 1340–1348. doi:10.1038/npp.2011.17
   PubMed Web of Science ®Google Scholar
• Wise, R. A. (2009). Roles for nigrostriatal—not just mesocorticolimbic—dopamine in reward and addiction. Trends in Neurosciences, 32(10), 517–524. doi:10.1016/j.tins.2009.06.004
   PubMed Web of Science ®Google Scholar
• Wolkowitz, O. M., Epel, E. S., Reus, V. I., & Mellon, S. H. (2010). Depression gets old fast: Do stress and depression accelerate cell aging? Depression and Anxiety, 27(4), 327–338. doi:10.1002/da.20686
   PubMed Web of Science ®Google Scholar
• Wood, P. L. (1983). Opioid regulation of CNS dopaminergic pathways: A review of methodology, receptor types, regional variations and species differences. Peptides, 4(5), 595–601. doi:10.1016/0196-9781(83)90003-7
   PubMed Web of Science ®Google Scholar
• Wu, L.-T., & Blazer, D. G. (2014). Substance use disorders and psychiatric comorbidity in mid and later life: A review. International Journal of Epidemiology, 43(2), 304–317. doi:10.1093/ije/dyt173
   PubMed Web of Science ®Google Scholar
• Yücel, M., Lorenzetti, V., Suo, C., Zalesky, A., Fornito, A., Takagi, M. J., … Solowij, N. (2016). Hippocampal harms, protection and recovery following regular cannabis use. Translational Psychiatry, 6(1), e710. doi:10.1038/tp.2015.201
   PubMedGoogle Scholar
• Yücel, M., Solowij, N., Respondek, C., Whittle, S., Fornito, A., Pantelis, C., & Lubman, D. I. (2008). Regional brain abnormalities associated with long-term heavy cannabis use. Archives of General Psychiatry, 65(6), 694–701. doi:10.1001/archpsyc.65.6.694
   PubMed Web of Science ®Google Scholar
• Zalesky, A., Solowij, N., Yücel, M., Lubman, D. I., Takagi, M., Harding, I. H., … Seal, M. (2012). Effect of long-term cannabis use on axonal fibre connectivity. Brain, 135(Pt 7), 2245–2255. doi:10.1093/brain/aws136
   PubMedGoogle Scholar
• Zehra, A., Burns, J., Liu, C. K., Manza, P., Wiers, C. E., Volkow, N. D., & Wang, G.-J. (2019). Cannabis addiction and the brain: A review. FOCUS, 17(2), 169–182. doi:10.1176/appi.focus.17204
   Google Scholar
• Zhang, H. Y., Chen, W. X., Jiao, Y., Xu, Y., Zhang, X. R., & Wu, J. T. (2014). Selective vulnerability related to aging in large-scale resting brain networks. PLoS ONE, 9(10), e108807. doi:10.1371/journal.pone.0108807
   PubMed Web of Science ®Google Scholar
• Zuardi, A. W., Crippa, J., Hallak, J. E. C., Pinto, J. P., Chagas, M. H. N., Rodrigues, G. G. R., … Tumas, V. (2009). Cannabidiol for the treatment of psychosis in Parkinson's disease. Journal of Psychopharmacology, 23(8), 979–983. doi:10.1177/0269881108096519
   PubMed Web of Science ®Google Scholar